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Background of human noroviruses 
 
Norwalk virus, the prototype norovirus was first recognized as a cause of 
gastroenteritis in 1972 by means of electron microscopy (EM) on stool samples. 
Norwalk virus was identified by visualization of small round virus particles in stool 
samples from infected students and contacts during an outbreak in Norwalk, Ohio, in 
1968. Originally norovirus was characterized based on the shape and structure by 
electron microscopic analysis. Later, immunological methods were applied however, 
these methods had serious limitations in accuracy and reproducibility and never 
provided a reliable scheme for antigenic classification of virus strains [1, 2]. In 1990, 
the first norovirus genome was sequenced , after which, researchers from the CDC 
Atlanta provided a systematic overview of the diversity of noroviruses (then named 
Norwalk-like virus [NLV]) based on sequencing and genetic characterization [3]. The 
norovirus were classified as a genus of the family Caliciviridae and the official name 
of norovirus was decided by the International Committee on Taxonomy of Viruses [4, 
5]. Norovirus was originally known as the etiological agent of winter vomiting 
disease, and is now considered to be the most common cause of acute gastroenteritis 
in both developed and developing countries worldwide [6]. 
 
Taxonomy of Caliciviridae  
Noroviruses belong to the Caliciviridae family, which is divided in 4 genera 
according the Class IV Baltimore scheme (Norovirus, Sapovirus, Vesivirus, Lagovirus 
[4]. Viruses of the genus Sapovirus are found in humans, swine, mink, and Lagovirus 
is found in rabbits and brown hares. The known host species for Vesivirus are sea 
lions, swine, cats, fish, dogs and primates and the recently identified Nebovirus genus 
is found in cattle [7]. Two additional genera have been proposed recently:  Recovirus, 
detected in stool specimens of Rhesus monkeys [8] and Valovirus in swine [9], but 
these two genera have yet to be classified. 
The genus Norovirus is divided into 5 genogroups based on whole genome sequence 
and similarity across the capsid gene [10, 11]. Viruses in genogroups I, II, and IV are 
10 
 
known to cause illness in humans, although genogroup II is also found in swine [12] 
and genogroup IV is also found in lions and canines [13]. Genogroups III and V 
viruses mainly infect bovine and murine species, respectively [12]. Genogroup II 
noroviruses are found in many outbreaks, whereas genogroup I noroviruses are more 
commonly involved in food-borne transmission, particularly in restaurants and on 
cruise ships [14-17]. Each genogroup is further subdivided into genotypes based on 
sequence similarity across the capsid gene [10, 18]. In the last years, the GII viruses, 
particularly the emerging GII.4 genotypes, have caused more than 90% of all 
outbreaks worldwide [19]. New variants of this genogroup (-type) emerge almost 
every other year and spread globally [20].  
 
Genome organization 
 
The virus particles are 28-32 nm in diameter. Noroviruses have been characterized as 
non-enveloped viruses with a genome consisting of a positive sense, single-stranded 
RNA strand of approximately 7.3-7.7 kb long. It encodes 3 open reading frames 
(ORFs), of which; ORF 1 is the largest (approximately 1700 amino acids) and is 
expressed as a nonstructural polyprotein precursor that is cleaved by the viral 3C-like 
protease. The proposed six non-structural proteins encoded in the norovirus ORF1 
defined so far are, from N to C terminus: p48-NTPase-p22(p20)-VPg-3CLpro-RdRP 
[5, 21]. The RdRp region is a conserved region, and therefore is often used as a target 
in detection assays based on RT-PCR. ORF 2 encodes the viral capsid protein (550 
amino acids) that forms the shell and protruding domains divided into the P1 and the 
P2 domain. The latter domain is the most variable part of the norovirus genome. In 
addition, the protruding domain is connected to the shell by a flexible hinge allowing 
for some freedom to change shape, potentially resulting in mutations in the P1/2 
domains [22-26]. Expression of the ORF 2 proteins can result in self-assembled VLPs 
(virus like particles) with the same immunogenicity as the norovirus virions. For that 
reason, VLPs are often used for the development of antibody assays. The ORF 2 
fragment can also be used for genotyping and phylogenetic analysis. The final ORF 
(ORF 3) encodes a small basic protein that has been characterized as a minor 
promotor protein that increases expression of ORF 2 and stabilizes the capsid [27].  
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Clinical manifestations  
 
Noroviruses are considered mucosal pathogens and are characterized often by 
diarrhea and or vomiting; severe symptoms like bloody diarrhea are not seen [6]. 
However, norovirus infections can be disruptive when they occur in healthcare 
institutions, and recent studies have reported that norovirus infections can lead to 
mortality, particularly in the elderly [28] [29]. The incubation period is short: 24-48 
hours, but can last up to 72 hours whereas symptoms may last for 1-3 days. Illness 
may last longer in the elderly and in subjects with an immunosuppressed status [24, 
30, 31].  The most commonly reported symptoms include diarrhea, vomiting, 
abdominal cramps and nausea and in some cases low-grade fever, chills, headache, 
muscle aches and fatigue. In the United States alone an estimated 23 million cases of 
norovirus gastroenteritis occur annually, resulting in 50.000 hospitalizations each year 
[32, 33]. From all those infected with norovirus, up to one-third may remain 
asymptomatic [34]. To some extent, the clinical burden of norovirus has been 
established among infected volunteers in a human challenge study, showing that at 
least 69 % of the challenged volunteers developed symptoms, and continued to shed 
the virus up to approximately 8 weeks after challenge, well after clinical recovery 
[35]. A commonly reported long-term consequence of norovirus infection is irritable 
bowel syndrome [36]. In addition, norovirus infections may lead to more severe 
complications in the elderly and in people with underlying illnesses: dehydration, 
weight loss, renal failure, disseminated intravascular coagulation (DIC), chronic 
diarrhea for months to years, malnutrition, and even death [6, 37] 
 
Figure 1. Schematic overview of the norovirus genome including detail representation of 
the ORF II, showing the most variable domain (P2 domain), 
(http://emedicine.medscape.com/article/224225-overview#aw2aab6b2b2) 
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Shedding dynamics and symptoms 
 
Noroviruses are excreted via the fecal-oral route (via feces and vomit) with around 
10
8
, but up to 10
10
 RNA copies per gram stool for an average infected subject [38-40].  
In contrast, an infectious dose (e.g. ID50) of few virus particles is enough to infect 
susceptible individuals [41]. Therefore, noroviruses are considered to have a very low 
infectious dose and can remain infectious for a long period of time after deposition in 
the environment [41]  
An experimental study with Norwalk virus demonstrated that earliest onset of virus 
shedding was detected 18 hours post inoculation by RT-PCR and virus shedding 
lasted for a median of 28 days (range 13-56 days), thus demonstrating the extended 
intervals of shedding after recovery of subjects and the existence of asymptomatic 
shedding. The median peak shedding in this study was around 9.5x10
9
 genomic 
copies per gram stool samples as measured by the RT-PCR [35]. Individuals with 
symptomatic or asymptomatic norovirus infection shed virus for long periods of time, 
even after clinical recovery [38, 40]. The variation in numbers of viruses shed by 
infected subjects is considerable, ranging from 10
2
 to 10
10
 viruses (qPCR detected 
genome copies).  
The duration of shedding is also variable, with shedding in some subjects decreasing 
to undetectable levels within 2 weeks post infection, while in others shedding persists 
for up to 80 days. These factors potentially allow the virus to cause recurring 
outbreaks in crowded environments, like healthcare institutions, nurseries, and cruise 
ships. Anecdotal reports suggest that chronic shedders may play a role in sustaining 
the spread of infection, and also in producing new variants of the virus. The high 
infectivity of noroviruses and their short incubation period make them effective 
outbreak agents capable of causing many secondary and tertiary infections within a 
matter of days. 
 
 
 
Norovirus transmission 
 
Noroviruses can be transmitted by either direct contact (person to person), via 
contaminated fomites, or via food or water. The majority of the reported outbreaks are 
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associated with person-to-person transmission, particularly in crowded areas [20]. The 
virus can spread easily via droplets, aerosols of vomits, or fecal contamination, 
especially in absence of appropriate hygienic measures, for instance in healthcare 
settings and nursing homes. 
 
Another factor of concern is the introduction of the virus into the health care setting, 
from the community outside. When successful, such introductions are easily spread to 
cause nosocomial outbreaks within days. Specific pathways contributing to the spread 
of the virus are usually unknown. Surveillance of norovirus in patients admitted into a 
university hospital (EMC) between 2002 and 2007 has revealed a considerable 
number of nosocomial and community-acquired cases (figure 2.) [42] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Another common category of norovirus illness is food-borne outbreaks, linked to 
contagious food handlers or food contaminated at source (e.g. raspberries irrigated 
with surface water impacted by sewage). Such sources may cause outbreaks over a 
vast geographic region and are difficult to detect [43]. Due to the infectiousness of 
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Figure 2: Number of community acquired and nosocomial infection divided among age categories over a 
period of 5 years (2002-07) within the Erasmus Medical Center (EMC). 
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these agents, any introduction may result in an outbreak within a matter of days. 
Understanding the environmental pathways for transmission can help improve the 
scientific basis for control measures. Currently, much emphasis is put on increasing 
levels of hygiene in institutions during norovirus outbreaks, but sources of 
introduction have not been studied in sufficient detail [44]. Virus deposited into the 
environment during outbreaks is a factor of concern since it may enhance direct, 
secondary and tertiary infections wherever humans come into contact with such 
environments. Even when a stringent hygiene protocol is enforced for HCW, hygienic 
measures for elderly and severely ill patients remain difficult to control. 
 
 
Financial loss during outbreaks 
 
Outbreaks caused by norovirus are costly and difficult to control, even when stringent 
hygiene protocols are implemented. Outbreaks do not only cause substantial health 
impairment in patients and health care workers, but they also lead to considerable 
financial losses, due to ward closure, sick leave, lost revenues, replacement of 
supplies and cleaning. As previously reported [45], among other common pathogens 
as rotavirus, influenza virus and Clostridium, norovirus showed the highest ward 
closure rate of any nosocomial infection for at least 44.1 % of the outbreaks [45]. 
Departments providing care for older patients are closed more often than pediatric 
wards, due to lack of sufficient infection control measures such as patient isolation 
[45]. Recent studies have provided an overview of the magnitude of financial losses 
during an outbreak in a tertiary care hospital in Switzerland with costs up to 40.000 
USD. A similar affected hospital in the US calculated costs of at least 650.000 USD 
[33, 46]. In the Netherlands alone, the annual costs for norovirus at the national level 
were estimated to be between 33 and 69 million euros [47].  
 
 
During an outbreak there is a higher than normal need for nursing care for infected 
individuals. Due to sick leave of HCW, affected departments may experience 
seriously understaffed teams with abnormally high working pressure for the 
remaining personnel. As a result, extra costs are incurred, for hiring extra personnel 
and additional financial losses due a decrease in admissions of patients or residents 
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[46]. On top of these costs, even more expenses may be made, for instance hiring an 
infection control team to contain the outbreak. 
 
 
Diagnostic and detection  
 
Worldwide, various detection methods are applied for diagnosing norovirus infection.  
During outbreaks, stool samples are widely used for detecting Norovirus RNA. 
However, other materials like vomit, food, water and environmental swabs may also 
be used. To date, quantitative real time RT-PCR is the most sensitive and specific 
assay used in many clinical and research settings, and it therefore remains the method 
of choice [48]. The region of the norovirus genome that is targeted by this assay is 
highly conserved, allowing detection of almost all genotypes and variants. Because of 
the use of degenerate primers, and due to the high degree of variation among 
noroviruses, some strains may be missed in these assays, as has been shown using 
cloned run-off RNA transcripts as targets (Vennema et al, unpublished). The majority 
of the outbreaks are dominated by GII.4 strains, and therefore the small portion of 
missed cases is less relevant in clinical settings [49]. Modern adaptations have 
resulted in improvements towards more generic and broader detection methods. 
The use of quantitative RT-PCR requires sophisticated tools and highly trained 
personnel, which may present a barrier to implementation in laboratories around the 
world. Limitations of this assay are also the possible presence of inhibitors during 
amplification, inefficient RNA extraction, and degradation of norovirus RNA in 
specimens stored at suboptimal conditions.  
Historically, electron microscopy was used to identify noroviruses but the sensitivity 
is very low (<25%) compared to RT-PCR and enzyme immunoassays [50]. An ideal 
norovirus detection method would be a rapid and inexpensive, yet sensitive assay that 
allows onsite testing. Such methods are currently on the market but are less accurate 
than the RT-PCR [51-53].  
Despite improvements, the sensitivity of these enzyme immunoassays remains lower 
than that of RT-PCR [6, 54-56]. In an experimental study with Norwalk virus, 
detection of virus in stools could be measured by ELISA for a maximum of 10 days 
post inoculation, whereas RT-PCR allowed detection until at least 28 days following 
inoculation (ranging from 13-56 days). Therefore, exclusive use of this rapid test for 
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diagnosis is not recommended. However, for outbreak diagnosis this could be a 
valuable tool. To date, many institutions for health care, particularly nursing homes 
and centers for geriatric care, do not have norovirus detection assays implemented in 
their laboratories so that they are dependent on external testing. 
 
 
Outbreak detection 
 
The general definition of a norovirus outbreak is when at least two positive cases are 
found that are linked in time and place. Where norovirus diagnostic facilities are not 
available, outbreaks have been defined by use of the Kaplan criteria: a mean or 
median duration of illness between 12 and 60 hours and a mean incubation period of 
24 to 48 hours, with more than 50 % of subjects vomiting, and bacterial pathogens 
ruled out by routine culture [57].   
These criteria were based upon an in-depth analysis of 38 outbreaks of acute 
gastroenteritis caused by Norwalk virus between 1976 and 1980 [58]. Application of 
these criteria to distinguish outbreaks of acute norovirus gastroenteritis from other 
enteric pathogens has been associated with a sensitivity of ~70% and a specificity of 
up to 99 % [57, 59, 60].  
Given the relative insensitivity of these symptom-based diagnostic criteria, 
noroviruses cannot be excluded as the etiologic agent if outbreak characteristics fail to 
meet the Kaplan criteria and there is suspicion for a viral enteropathogen. 
In a different study, it was shown that finding a single positive sample among 2, 3 or 4 
samples, using either a standard RT-PCR or a commercially available ELISA, is 
sufficient to identify norovirus as the causative agent in an outbreak of acute 
gastroenteritis [61].  
 
 
 
Norovirus epidemiology  
 
Since 2002, the epidemiology of norovirus appears to have changed, with the 
introduction of a specific new GII4 variant. Since then, continued evolution has led to 
the emergence of 3 successive GII4 variants and the overall incidence of outbreaks 
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has remained at an elevated level, compared to before 2002 [23, 49]. Data from 
outbreak surveillance have also suggested that norovirus activity has increased since 
the global emergence of this GII4 variant [20].  
The majority of the outbreaks in health-care related institutions (nursing homes, 
hospitals) are associated with GII4 viruses, whereas a wider range of variants is seen 
in other settings such as schools, restaurants and catered events [49]. In the 
Netherlands, an average of 150 outbreaks is reported each year, mostly during the 
winter months, as well as an estimated 600.000-isolated cases of acute gastro-enteritis 
[62]. In addition to the increased frequency of outbreaks, an increase in the number of 
deaths associated with norovirus was observed in elderly, suggesting changes in the 
virulence of the virus [63].  
 
 
 
 
These outbreaks are difficult to control because of environmental contamination: 
the virus tends to remain infectious outside the host, and it is relatively 
resistant to commonly used disinfectants. Stringent hand washing routine and the use 
of chlorine-based disinfectants are proven strategies to reduce transmission of 
Figure 3: Number of total outbreaks reported, and number of norovirus outbreaks per month reported in 
the Netherlands (Source: passive surveillance of norovirus outbreaks, CIB) 
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norovirus. The widespread practice of low compliance to hand washing and the 
replacement of hand washing by the use of (fast) alcohol-based hand rubs in hospitals 
considered to be effective in the combat against MRSA - may have led inadvertently 
to an increased risk of spread of norovirus [64]. Hand rubs have also been introduced 
in the food industry. Increasing the alcohol percentage to 95% appears to have some 
effect on reduction of contamination of a model virus (2-3 10log units), but its 
efficacy as an intervention in the field remains unproven. Studies on the effectiveness 
of different hygiene protocols are currently underway, but have shown limited 
success. Molecular surveillance data suggest a specific contribution of GII4 variants 
to the increased burden of illness in health-care settings. Therefore, understanding 
how these virus variants emerge and spread in hospitals and nursing homes may 
provide clues to improve targeting of prevention strategies 
 
 
Molecular epidemiology in outbreak characterization and transmission events 
 
Molecular sequence data of norovirus is often used for diagnostic purposes. As 
described in this thesis, mapping of clusters defining nosocomial transmission of 
norovirus can be entirely based on epidemiological information such as concurrent 
location and timing. However relying solely on epidemiological data ignoring any 
genomic sequence data can lead to misclassification of outbreaks and errors in cluster 
mapping.  
For outbreak containment, molecular epidemiology can be used to verify links, 
between outbreaks and between subjects within outbreaks, providing new insights into 
the transmission of noroviruses. Both molecular and epidemiological data can be 
analyzed to unravel the transmission network during outbreaks [44, 65, 66]. 
Given the transmission network, the influence of preventive measures can be studied, 
to assess their effectiveness in limiting transmission and reducing the numbers of 
infections within a particular setting.  
Since norovirus has the ability to mutate rapidly, understanding the rate of genetic 
change is essential for the design of evidence-based sequence typing for use in 
epidemiological studies.  
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Summary 
 
To understand transmission pathways of norovirus between the general population 
and health care settings a standardized approach to outbreak investigations using 
novel methods developed and validated in an academic setting is needed. Importantly, 
collecting data on extent of transmission of norovirus during outbreaks, factors 
contributing to their introduction and spread, and data on diversity of the genomes of 
viruses shed by people over subsequent chains of transmission can be used to design 
evidence based control measures. 
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Scope of this Thesis 
 
 
The aim of this study was to generate virological and epidemiological data on 
transmission of norovirus that are needed to inform policy makers on optimal 
targeting of prevention and intervention strategies for control of norovirus outbreaks 
in high risk settings. Specifically, we aimed to understand modes of transmission and 
sources of norovirus in outbreaks, with an emphasis on transmission within healthcare 
settings and between health care settings and the general population, and to assess 
whether norovirus infection in risk populations could serve as a reservoir for the 
generation of new variant norovirus strains. Finally, this thesis aims to develop 
evidence-based criteria for use of molecular typing data in source tracking and to 
provide evidence-based guidelines on options for prevention of norovirus outbreaks 
using the knowledge collected on transmission chains. 
 
In chapter 2 we evaluated the underdiagnosis of sporadic norovirus infections in a 
tertiary care hospital and estimated its clinical impact. From December 2008 until July 
2009, fecal samples specifically referred for bacterial but not viral examination were 
retrospectively tested for norovirus by real-time PCR. The clinical and virological 
data from patients with undiagnosed (missed) norovirus infection were evaluated and 
compared with those from patients with recognized norovirus infection. In chapter 3 
we performed a retrospective follow-up study using a large historic data set of 
norovirus cases diagnosed between 2002-2007. Nosocomial transmission was re-
evaluated on the basis of a combination of molecular and epidemiological cluster 
mapping. Admission and sampling dates were used to differentiate between patients 
with nosocomial infection and those who acquired their infection extramurally. 
Clusters were identified by sequencing the most variable P2 domain.  In chapter 4 we 
performed a prospective study aimed at evaluating sources and modes of transmission 
during norovirus outbreaks within 2 types of institutions for health care. An inclusive 
outbreak protocol was developed to sample all patients and healthcare workers 
(HCWs) with and without symptoms on wards involved in outbreaks. Additional 
information was collected via questionnaires provided to each participant. The 
epidemiological data were used to construct plausible transmission pathways and 
corresponding reproduction numbers for symptomatic and asymptomatic patients and 
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HCWs. In chapter 5 an in-house available suite of RNA constructs for human 
norovirus was used to quantify the numbers of viruses shed, translating observed CT 
values into virus concentrations, in samples from symptomatic and asymptomatic 
infected subjects. In order to study the excretion of norovirus a quantitative dynamic 
model was fitted to the excretion data in follow-up samples of infected subjects, using 
a multilevel Bayesian framework to allow for individual variation in shedding 
kinetics. In chapter 6 we summarized the shedding data from both symptomatic and 
asymptomatic subjects and compared shedding and P2 domain variation in all 
included patients and HCWs during all studied outbreaks. This was done to 
investigate genetic sequence changes in order to validate the criterion used in tracking 
transmission patterns that was based on 100 % sequence similarity. In chapter 7 we 
review the additional data collected through responses to questionnaires, considering 
subject status of different types of HCW and patients and their contributions to 
transmission in each outbreak. We also looked at how the virus might have been 
introduced: types of food consumed, environmental factors such as (symptomatic) 
contacts or family members of infected HCW/admitted patients, with emphasis on 
index cases and their contribution to the spread of the virus. In chapter 8 we 
described virus shedding of three chronic shedders in hospital outbreaks, showing that 
chronically ill patients shed virus for a long period of time and that such patients 
potentially act as a reservoir of norovirus transmission. Finally, in chapter 9 we 
discuss the obtained results and some important mechanisms and their contribution to 
prevent or at least minimize future norovirus outbreaks in health care settings. 
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Abstract  
 
Noroviruses (NoVs) have emerged as the leading cause of acute viral gastroenteritis (GE) in 
humans. Although diagnostic facilities have greatly improved, significant underdiagnosis of 
NoV in hospitals may still occur, thereby increasing clinical burden and nosocomial spread. 
We evaluated the underdiagnosis of sporadic NoV infections in a tertiary care hospital and 
estimated its clinical impact. From December 2008 until July 2009, fecal samples specifically 
referred for bacterial but not viral examination were retrospectively tested for NoV by real-
time PCR. The clinical and virological data from patients with undiagnosed (missed) NoV 
infection were evaluated and compared with those from patients with recognized NoV. 
During the study period, 45 patients with undiagnosed NoV were detected, whereas 50 
patients had been regularly diagnosed. The missed NoV cases more frequently were adults 
(80% vs. 46%, p <0.001). The viral load levels did not differ between the diagnosed and 
missed patients, but missed patients more frequently presented without diarrhea (20% vs. 4%; 
p<0.07). The newly admitted missed NoV cases with GE underwent more diagnostic imaging 
(24% vs. 4%; p<0.01) and tended to be hospitalized longer. When missed NoV patients were 
included, the number of nosocomial clusters doubled and missed patients were index cases in 
5 of the 6 clusters. These data indicate that NoV infections are frequently missed despite 
routine laboratory testing and demonstrate that underdiagnosis of NoV patients is associated 
with costly abdominal imaging and nosocomial clustering. Awareness for NoV infection in 
adult patients and education about the importance of viral GE should be increased. 
 
 
Keywords: norovirus; sporadic; underdiagnosis; hospital; clustering; clinical impact 
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Introduction    
 
Noroviruses (NoVs) have emerged as the one of the most important pathogens 
causing acute gastroenteritis (GE) in children and adults (12, 8). Nursing homes and 
hospitals are widely confronted with NoV outbreaks. Additionally, isolated (sporadic) 
cases of NoV frequently occur, but their incidence and clinical impact in hospitals 
have not been studied systematically (2, 17). Sporadic cases of NoV may result both 
from community acquired infections in newly admitted patients and from nosocomial 
transmissions between patients, personnel or visitors (9). Although sensitive 
commercial and homemade diagnostic assays for NoV have become widely available, 
sporadic NoV infections in hospitalized patients remain underdiagnosed, increasing 
clinical burden and potential for nosocomial spread (1, 4, 21). Underrecognition of 
NoV may result in the individual patient undergoing more diagnostic procedures and 
may increase the influx of infectious patients into hospital wards where they may 
trigger outbreaks (5, 14). Apart from suboptimal laboratory facilities and inadequate 
specimen collection, underdiagnosis of NoV may also result from a referral bias. This 
bias may occur when physicians selectively refer GE patients for bacteriological or 
parasitological testing but not virological testing. In the present study, we 
prospectively evaluated underrecognition of NoV patients in a tertiary referral center 
with separate testing for viral and bacterial pathogens. For this purpose, the aliquots of 
fecal samples referred for bacteriologic testing were stored and retrospectively 
examined for NoV during a 6.5-month period, which included the NoV seasonal peak. 
The characteristics of missed NoV patients and the clinical impact on diagnosis, 
duration of hospitalization, and infection prevention were evaluated. 
 
 
Patients and Methods 
 
Patients 
 
The Erasmus Medical Center (EMC) and its affiliated hospitals comprise a 1100-bed 
university hospital, a 269-bed children hospital, a 137-bed oncology center, and a 
160-bed non-academic general hospital. From December 16, 2008 until July 1, 2009, 
patients from the EMC and affiliated hospitals were included in the study. Physicians 
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can refer patients with gastroenteritis (GE) for either bacteriological, virological, or 
parasitological testing, or any combination of these options. During the study period, 
patient samples referred for virological testing were routinely tested for NoV, whereas 
samples referred for bacteriological testing were aliquoted and stored at -80°C for 
NoV testing at a future time. Per patient, an authorized member of the medical staff 
accessed the following information: age, sex, date of hospitalization, results of 
bacteriological stool cultures, and clinical information from the virology and 
bacteriology database. The presence or absence of diarrhea was recorded in the 
laboratory.  If stool samples showed no watery diarrhea, data from the medical 
records were reviewed to confirm the presence or absence of diarrhea. The data were 
anonymized with a unique code and entered into a separate database for use by the 
study team. The NoV RNA positive samples were stored for genotyping.  
 
 
Detection of bacterial pathogens 
 
Collected stool samples were inoculated onto McConkey (MC) agar (Difco, BBL), 
Salmonella-Shigella (SS) agar (Difco, BBL) and taurocholate tellurite gelatin agar 
(TTGA)  and Brucella agar (Difco, BBL) supplemented with 5% sheep's blood and 
five antibiotics (amphotericin B, cephalothin, polymyxin B, trimethoprim, 
vancomycin) for the isolation of Salmonella, Shigella, Vibrio and Campylobacter spp. 
respectively. All the plates were incubated at 37°C for 18–24 h except for Brucella 
agar, which was incubated at 42°C in an anaerobic jar with a CampyGen pack 
(CN0025, Oxoid Ltd, UK) for 48 h. Along with direct streaking, each sample was 
enriched in selenite broth (Difco, BBL) and bile peptone broth at 37°C for 18–24 h to 
enhance the isolation of Salmonella spp. and Vibrio spp., respectively. The 
enrichment broth for Salmonella was subcultured onto SS agar and the enrichment 
broth for Vibrio was subcultured onto TTGA agar and incubated at 37°C for 18–24 h. 
Bacterial enteric pathogens were identified by colony characteristics, and by 
biochemical tests using conventional and API 20 biochemical profiles (bioMérieux, 
France) when necessary. Isolates were further confirmed serologically using 
commercially available specific antisera (Denka Seiken, Japan). Campylobacter spp. 
isolates were differentiated as C. jejuni and C. coli by the hippurate hydrolysis test.  
Cefsulodin-irgasan-novobiocin (CIN) agar was planted for isolation of Yersinia 
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enterocolitica. Faeces were evaluated for Clostridium difficile toxin by 
ImmunoCard® Toxin A and B (Meridian Bioscience).  
 
 
Detection of norovirus by Real Time PCR  
 
Two hundred  µg feces (200 µl if liquid) were suspended in 600 µl star buffer that had 
been preheated in a 37°C water bath. Each tube was vortexed briefly, and 80 µl of 
chloroform was added. After vortexing, samples were clarified by centrifugation for 1 
minute at maximum speed (Eppendorf 4515 R). A 190 µl aliquot of supernatant and 
10 µl of an internal control were transferred to the Magna Pure LC Isolation plate for 
RT-PCR (program: total nucleic acid extraction according to the manufacturer’s 
instruction; MagNa Pure LC) with an elution volume of 50 μl (Roche Diagnostics 
GmbH). For detection, 20 μl RNA extractions were reverse transcribed to cDNA with 
random hexamers using the MultiScribe™ Reverse Transcriptase kit (Applied 
Biosystems) according to the manufacturer’s instructions. Subsequently, the cDNA 
was used in a Real-Time NoV PCR assay for qualitative analysis (2, 11).  
 
 
Molecular analysis of norovirus 
 
cDNA was amplified by a semi-nested PCR and subsequently region A of the 
polymerase gene was sequenced using the ABI-PrismBigDye Terminator v3.0 Ready 
Reaction Cycle kit (ABI Prism 7700 Sequence Detection System (Applied 
Biosystems, Foster City, CA, USA) as described (20). Sequences were  assembled in 
bionumerics (Applied Maths, Sint-Martens-Latem, Belgium, software package 6.6.4),  
evaluated manually for their quality by looking for the number of ambiguities, errors, 
mismatches and deletions , and genotyped with an NoV-genotyping tool (URL: 
http://www.rivm.nl/mpf/norovirus/typingtool)(13). Phylogenetic analysis (UPGMA, 
Multiple alignment) was done to identify links between strains for each genotype 
(variant) separately. 
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Nosocomial transmission 
 
Given an incubation period for NoV of one to three days, community acquired NoV 
infection was assumed if stool had been sampled in relation to GE complaints and 
within one day of admission. Nosocomial transmission of NoV was assumed if 
patients had been sampled for the first time more than 5 days after admission, as 
described (2). From the patients sampled on days 2-5 after admission, clinical 
information about the presence of GE symptoms at the first day of admission was 
used to differentiate between nosocomial and community acquired NoV infection. 
Clustering of NoV infections was defined as the presence of 2 or more patients with 
NoV in one ward within 5 days after the onset of disease, with at least one 
nosocomially infected patient (2). In addition, the patients had to be part of a 
molecular cluster, A molecular cluster was assumed  if strain sequences were identical  
(for a 200bp region A pol gene fragment) or had maximally 1 mismatch over a 600bp 
fragment of the polymerase gene . This approach was validated by comparison with 
strain sequences entered into the noronet database around the same period of time 
from other parts of the country as well as internationally.  Only the admitted patients 
were included in the cluster analyses. 
 
Statistical analyses 
 
The clinical and laboratory data from patients initially suspected of and diagnosed 
with an NoV infection (recognized NoV patients) and those of patients suspected for 
bacterial GE with an undiagnosed NoV infection (missed patients) were compared 
using the SPSS statistical software package (version 15; SPSS, Chicago, IL, USA) 
and SAS (version 9.2 for Windows; SAS Institute Inc., USA). The Mann-Whitney U 
test (two-tailed) was used to compare the average length of stay in the hospital for 
recognized NoV patients and missed patients. P values <0.05 were considered 
statistically significant. Logistic regression analysis was performed to determine 
which of 19 variables (Table 1) could be identified as univariate predictors of a 
missed NoV infection. Those variables with a p-value of less than 0.20 in the 
univariate analysis were included in the multivariate model. The variables remained in 
the multivariate model if the p value was less than 0.10, whereas the backward 
selection procedure was used. The missing values were classified as unknowns so that 
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the maximum number of cases was included in the multivariate logistic regression 
model. The analyzed variables were included as continuous variables where possible 
or categorized based on 50-percentiles in the group of recognized NoV cases.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.  Characteristics and clinical parameters of recognized and missed NoV patients in a tertiary 
care hospital from 16 December 2008 to 30 June 2009 
 
 
a 
Comm. -acq., community-acquired 
b 
Nosocomially infected and/or asymptomatic patients 
c
 Values in boldface are statistically significant. 95% CI, 95 % confidence interval; NS, nonsignificant; 
*, Mann Whitney U test (two-tailed). 
 
 
Parametera 
Value for undiagnosed 
patiënts (N=45) 
  
Value for diagnosed 
patiënts (n=50) 
  . 
Univariate analysisc 
 
      OR               95% CI 
Gender male 58 26/45 40 20/50 ns  
Mean age (years)  42  31   
Age in categories:  ≥18 80 36/45 46 23/50 4.7 (1.87-11.8) 
Outpatient  21  10/45) 10  (6/50) ns (0.69-6.33) 
Admitted with comm. acq. GE 40 (18/45 40 (20/50) ns  
Admitted without GE symptoms # 38 (17/45) 49 (24/50) ns  (0.29-1.49) 
Pre-existing disease(s)    53 (24/45) 63 (30/46) ns   
Immunocompromised   31 (14/45) 43 (21/50) ns  
Chronic NoV   4 (2/45) 2   (1/50) ns  
Vomiting  42 (13/31) 50 (19/38) ns  
Diarrhea 80 (28/35) 95 (39/41) 0.21 (0.04-1.06) 
Abdominal imaging 24 (11/45) 4  (2/50) 7.76 (1.62-37.3) 
Mean Ct value (cycles)  24,4  24,6   
Illness duration at diagnosis (days)  4.7 days n=28  3.8 days n=39 ns*  
Admission duration  total (days) 16.3 days n=33 18.1 days  n=45 ns*  
Admission comm. acq. (days)    6.2 days  n=17    4.7 days       n=20 ns*  
Clustering (patients)  15 3x (2.2.2) 16 3x (3.2.2)     
Mortality 1 month 2 (1/45) 2 (1/50) ns  
Mortality 1 year 9 (4/45) 6 (3/50) ns  
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Results 
 
Samples and patients 
 
From December 2008 until July 2009, 1809 patients were tested in the departments of 
virology (606 patients) and bacteriology (1203 patients) of the EMC. In the virology 
department, 50 patients (8%) tested positive for NoV (called “recognized NoV 
patients”). Among the patients submitted for bacteriological testing, our retrospective 
analysis revealed 45 (4%) additional NoV patients (“missed patients”), which had not 
been diagnosed in the virology department (Fig.1). For all patients combined, the 
diagnostic yield was 5.3% (95/1809). 
 
 
 
    
 
Figure 1. Missed norovirus infections in relation to bacterial infections in stool samples of patients 
(n=1203) sent for bacteriological culture during Dec. 2008 – July 2009. Clos.: Clostridium difficile; 
Camp.: Campylobacter spp; Salm.: Salmonella spp; Shig.: Shigella spp; Yers.: Yersinia spp. 
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Characteristics and clinical symptoms of recognized and missed patients 
 
The characteristics of the recognized (n=50) and missed (n=45) NoV patients are 
shown in Table 1. When compared to the recognized patients, missed patients more 
frequently were adult (age≥18) (80% vs. 46%; p<0.01), male (58% vs. 40%; p=0.1) or 
outpatient (21% vs. 10%; p=0.27). A substantial number of NoV patients in both 
groups suffered from underlying diseases (51% vs. 63%) or were 
immunocompromised (31% vs. 42%), but these differences were not significant. 
Missed patients with NoV infection were more frequently from the affiliated non-
university hospital (24% vs. 6%; p<0.02) but not more frequently related to a specific 
ward or department. Most of the clinical and virological characteristics were similar 
for recognized and missed NoV cases. These characteristics included viral load levels 
in fecal samples, reflected by a mean cycle threshold (Ct) of 24 for both groups, and 
the presence of vomiting (42 vs. 50%). However, diarrhea was less commonly 
reported for the missed patients (80% vs. 95%; p=0.07). Most patients not reporting 
diarrhea (n=9) were adults with complex underlying conditions, such as cancer liquid 
feeding, or end-stage diseases. In two other patients, stool samples had been taken in 
the context of a bacteriological screening protocol. Fot both missed en recognized 
patients, the patients without diarrhea had significantly more often high Ct values (> 
25) compared to the patients with diarrhea (6/2 vs 24/43; OR 5,4  p<0,05).   
 
 
Factors associated with missed NoV cases 
 
In logistic regression analysis, 9 of the 19 investigated factors were associated with 
being a missed NoV case (Table 2). In multivariate analysis, the following factors 
were independently associated with being a missed case: abdominal examination and 
admission to the affiliated general (non-academic) hospital. The factors identified to 
be independent indicators of recognized cases were admission at the children’s 
hospital, symptoms of diarrhea and higher age (in years). The effect of risk of higher 
age is no longer present after correcting for hospital departments.  
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Hospitalization and diagnostic imaging 
 
Twenty-eight missed patients (10 outpatients and 18 newly admitted patients) had 
been infected outside the hospital (community acquired NoV). The presumptive 
diagnosis for these patients at presentation is shown in Table 3. For 25 (86%) of the 
patients, the presumptive clinical diagnosis was not confirmed, and NoV infection 
was the likely explanation for the clinical symptoms in all of these cases. In two 
patients, the presumptive diagnosis was confirmed. However NoV infection was 
clinically relevant in one of these patients. 
 
 
Table 2. Risk ratios and 95% confidence intervals for independent associations between different 
variables and missed norovirus cases
a
 
 
a
Patients were in a hospital population from 16 December 2008 to 30 June 2009. Values are from 
univariate and multivariate logistic regression analysis. Boldface indicates statistically significant 
difference. Ref, reference category; NS, not significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Univariate analysis Multivariate analysis 
Variable Category No. 
of 
OR 95% CI OR 95% CI 
Gender Female 49 Ref  Ref  
 Male 46 2,1 (0.9-4.7) ns  
Age in years continuous 90 1,01 (1.00-1.03) 0,95 (0.91-0.98) 
Age in categories <18 36 Ref    
 >=18 59 4,7 (1.9-11.8)   
Hospital visit due to acute GE (5 not 
diagnosed) 
No 45 Ref  Ref  
 Yes 45 0,4 (0.1-1.5) ns  
Admission duration (1 not diagnosed) 0 (outpatients) 16 Ref  Ref  
 1-9 days 38 0,5 (0.1-1.7) ns  
 >9 days 40 0,3 (0.1-1.0) ns  
Group University adults 45 Ref  Ref  
 University children 36 0,3 (0.1-0.7) 0 (0.0-0.2) 
 other 14 2,9 (0.7-12.0) 5,2 (1.0-27.7) 
Symptoms of acute GE (18 missing) No 7 Ref  Ref  
 Yes 70 0,3 (0.1-1.7) ns  
Diarrhea (19 not diagnosed) No 9 Ref  Ref  
 Yes 67 0,2 (0.0-1.1) 0,1 (0.0-0.8) 
Abdominal examination No 82 Ref  Ref  
 Yes 13 4,5 (1.1-17.5) 11,7 (2.3-58.0) 
Kidney failure No 82 Ref  Ref  
 Yes 13 0,3 (0.1-1.1) ns  
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A total of 11 missed patients underwent abdominal imaging (including abdominal 
echo, X-ray, computerized tomography (CT) scan or duodenal/colonoscopy) during 
their diagnostic work-up for acute GE. When compared to the recognized patients, 
abdominal imaging occurred significantly more often in the missed patients (24% vs. 
4%; p<0.01) (Table 2 and 3). Most (8 out of 11) of the missed patients with diagnostic 
imaging had underlying diseases. The imaging in these patients usually was 
performed to exclude exacerbation, complications, or progression of these underlying 
diseases, although in one patient the imaging was part of a routine control. In all three 
patients without underlying disease the diagnostic imaging was performed to explain  
abdominal complaints that potentially might have been due to NoV infection.  
Finally, duration of hospitalization was compared between the newly admitted 
recognized (n=17) and missed patients with NoV (n=20). Overall, the duration of 
hospital stay for those with the community acquired NoV tended to be longer for the 
missed patients (6.2 days vs. 4.7 days) but the difference did not reach statistical 
significance (Mann Whitney u test: p=0.48).    
 
 
Nosocomial spread and clustering     
 
We evaluated nosocomial clustering in the recognized and missed hospitalized NoV 
patients. For this analysis we excluded the outpatients. Apart from clustering in time 
and place, genotyping was performed to link the cases within the hospital as described 
in the method section. When only the recognized patients were considered, three 
clusters consisting of 2 patients each were present. When missed NoV patients were 
included, 3 more clusters of 3, 2, and 2 patients each would have been recognized. 
Furthermore, two of the previous clusters would have increased with 3 and 1 patients, 
respectively, and one cluster would have been identified 4 days earlier. Based on the 
onset of disease symptoms, missed patients were designated as index cases in 5 of the 
6 clusters.  
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Discussion 
 
The present study was initiated to assess the potential underdetection of NoV as a 
cause of illness in patients admitted to the hospital or during hospital stay by 
retrospectively analyzing stool samples that were sent to the laboratory to exclude 
bacterial causes of intestinal complaints. We found that this approach approximately 
doubled the number of recognized NoV shedders and that the missed NoV patients 
underwent significantly more diagnostic imaging for GE, including colonoscopies, 
computed tomography, and X-ray examinations. This underrecognition of NoV 
mainly originated from inadequate referral to the laboratory by clinicians and 
therefore occurred regardless of the availability of a routine diagnostic NoV RT-PCR 
offered on a daily basis. To our knowledge, this routine is not atypical, and therefore, 
similar rates of underdiagnosis may occur in many hospitals (10, 21). We 
demonstrated not only that patients with unrecognized NoV infection had 
significantly more costly additional non-laboratory procedures but were also most 
likely sources for nosocomial infection in 5 instances during the relatively short 
period of time evaluated. Therefore, the results are relevant not only for individual 
patients but also for hospital infection control and for tracing NoV transmission 
chains. 
Underdiagnosis of NoV occurred significantly more frequently in adults (60%) than in 
children (26%). However, this difference was no longer present after correcting for 
hospital departments, which suggests that the increased risk for underdiagnosis in 
adults likely relates to a low awareness of viral GE among physicians in adult wards 
rather than the patient's age. Alternatively, the general awareness for rotavirus in 
children might contribute to the effective recognition of viral GE including NoV 
infections in children.  
Several recent studies underscore that NoV infection affects people of all ages and can 
cause severe disease in elderly and immunosuppressed individuals (3, 4, 10, 15, 18, 
19). In our study, the relevance of NoV infections in adults was emphasized by the 
finding that NoV infections in adults largely exceeded the number bacterial GE 
infections based on the currently used methods for detection (59 vs. 36 patients).  
The clinical characteristics and mean viral loads of the missed NoV patients were 
comparable to those of the recognized patients. This indicates that missed patients 
were not predominantly patients with a mild or late stage of disease or with a low 
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viral load. The only exception on this was the finding that significantly more missed 
NoV patients reported an absence of diarrhea when compared to diagnosed patients 
(14% versus 5%). However, the absolute number of missed NoV patients without 
reporting diarrhea was low, and most of these patients had complex underlying 
diseases for which diarrhea may not have been reported explicitly. 
 
 
 
 
Comparing the clinical parameters between missed and recognized NoV patients, our 
study highlights the clinical impact of missing NoV infections within the hospital 
setting. First, the results demonstrate that missed NoV patients were involved in 5 out 
of 6 nosocomial clusters that occurred during the study period. Excluding the missed 
NoV patients, only three such clusters would have been recognized, one of which 
would have been at a later point in time. In all five clusters, the index was found to be 
a missed patient, which suggests that diagnosing these missed patients could 
Table 3.  Presumptive diagnosis and abdominal imaging results for missed NoV patients presenting at 
the emergency room with community-acquired NoV infection
a
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
a
 Twenty-eight NoV patients presented at the emergency room with community-acquired NoV 
infection. CU, colitis ulcerosa; CT, computed tomography; CMV, cytomegalovirus; echo, abdominal 
echo. 
b
+, presumptive diagnosis confirmed 
c
+, NoV infection retrospectively explained the clinical symptoms 
d
 Routinely tested. 
 
 
 
 
Presumptive diagnosis Abdominal imaging  Diagnosis confirmedb  NoV relevantc 
Cholecystitis    - + - 
Subacute bacterial peritonitis Sigm.scopy +  echo + + 
Aids related pneumonia     - - + 
Inflammatory bowel disease  echo + colonoscopy 
d
   - + 
C. difficile, exacerbation CU X-ray + Sigm.scopy - + 
Protein-losing diarrhea. X-ray + scopy (2x) + CT . - + 
Addison crisis    - - + 
Food-poisoning X-ray - + 
Renal dysfunction  (n=3)    - - + 
Thymoma, Giardia, CMV  Endoscopy + CT. - + 
Graft versus Host Disease    - - + 
Coeliac disease, CU,  M.Crohn.  Echo  - + 
Diverticulitis Sigm. scopy - + 
AIDS presenting symptom    - - + 
Ileus  X-ray - + 
Tropical infection (n=2)    - - + 
Bacterial infection (n=10)    - - + 
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effectively improve the timely institution of infection preventive measures. Friesema 
et al. recently reported a beneficial effect of the early institution of preventive 
measures for NoV. (7). Second, we found that missed NoV patients underwent 
significantly more abdominal imaging than recognized patients, including 
colonoscopy, computed tomography, and abdominal X-ray examination. These 
investigations usually were requested in relation to abdominal complaints (3 patients), 
but also to exclude exacerbations and complications of preexisting conditions (8 
patients). Our findings that most (9 out of 11) imaging remained negative and that the 
recognized patients had similar underlying diseases but significant less imaging, 
support the view that physicians may request less diagnostic imaging when norovirus  
is diagnosed. In this context it should be stressed that the mere presence of norovirus 
should not always exclude other causes of GE, since the infection can be 
asymptomatic in patients, especially when the viral load is low. Third, a subgroup 
analysis of the newly admitted patients with community-acquired GE showed that 
hospitalization tended to be longer for the missed NoV patients when compared to 
recognized patients. Although not statistically significant (p<.0.1), this difference may 
indicate that the laboratory diagnosis of NoV enables a more rapid discharge of newly 
admitted patients with GE. 
Although we assumed that hospitalized patients with symptomatic GE were routinely 
sampled to eliminate an infectious cause, it is possible that in a small number of 
patients, notably those patients with only mild or no symptoms, no sampling was 
performed. Consequently, the underascertainment of NoV patients might be even 
higher than we report here. Furthermore, we did not address undiagnosed NoV 
infections among hospital personnel, although recent studies have indicated that 
infected personnel can play an important role in the NoV transmission chain (16).  
Hence, appropriate collection and testing in both patients and personnel will be 
required for developing new evidence-based strategies to prevent the introduction and 
spread of NoV (20). The presented data demonstrate that a substantial level of 
underdiagnosis of NoV may occur in hospital settings and stress the need for 
education about the importance of viral GE to physicians in these settings. Since our 
results confirm that missed NoV patients are associated with increased clinical burden 
and nosocomial clustering, routine testing for NoV in adult patients with GE during 
the NoV seasonal peak likely will be cost-effective (6). 
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Abstract  
 
 
Background. Nosocomial norovirus (NoV) infection is common and may lead to 
complications in vulnerable hospitalized patients. Understanding sources and modes 
of transmission of noroviruses within health care settings will support the design of 
evidence-based strategies for reducing introduction and further spread.  
Methods. We sequenced a highly variable segment of the genome to identify possible 
clusters, in patients with and without acute gastroenteritis hospitalized from 2002-
2007.  Admission and sampling date were used to separate patients with nosocomial 
infection from those who were not nosocomial.   
Results. Epidemiological clustering retrieved 22 clusters defined as ≥2 nosocomially 
infected patients on the same ward within five days. In total, 264 patients (out of 2458 
tested) were diagnosed with NoV, and 61 % of the patient strains could be genotyped.  
Of those, 51 % (n = 82) belonged to GII.4, 34% (n = 54) to GII.3, and 15 % (n = 24) 
belonged to other genotypes (GI.6B, GII.17, GII.7, and GII.2). In children’s wards, 
GII.3 strains were more often associated with nosocomial spread than other viruses, 
whereas in adults this was the case for GII.4 strains. Sequence alignment recognized 
eleven new clusters based on identical P2 domains (4 GII.3 and 7 GII.4), involving 
patients in different wards. This increased the total number of recognized clusters by 
50 %.  
Conclusion. Five of these clusters involved at least one out-patient, providing a 
possible target for improvement of infection control. We conclude that the use of 
sequence-based typing should be considered for identifying hidden nosocomial 
clusters of NoV infections within health care settings. 
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Introduction 
 
Noroviruses (NoV) belong to the family Caliciviridae, and are the most common 
cause of acute viral gastroenteritis worldwide (11). Noroviruses have a positive sense 
RNA genome with an average length of 7.5 kb (4, 8). Noroviruses are genetically 
highly variable and are classified into 5 genogroups (GI, GII, GIII, GIV and GV), 
three of which are found in humans (12, 24). 
NoV are usually transmitted from person to person, but may also spread via 
contaminated surfaces, food and water (17). NoV outbreaks are common, particularly 
affecting health care institutions such as nursing homes and hospitals, but their impact 
and modes of transmission have not been assessed systematically (1, 6, 18). 
Previously, we described a high frequency of nosocomially acquired infections by 
comparing time of diagnosis and date of hospitalisation of newly diagnosed patients 
(1). There is evidence for increased health expenditures and possible complications in 
high risk patients of nosocomial norovirus infections, showing that studies are 
required to develop effective methods for reducing nosocomial infections (23). A 
study examining the efficacy of control strategies found that implementation within 3 
days after the first cases was the only factor that significantly reduced the size and 
duration of NoV outbreaks in nursing homes, regardless of the infection control 
protocol that was followed (5). Furthermore another study monitoring gastroenteritis 
outbreaks in England demonstrated the potential effectiveness of ward closure in 
hospitals (15). This shows that timely detection of nosocomial spread is a key 
determinant of successful control activities (7, 9, 21). We therefore investigated the 
possible use of molecular typing in addition to routine monitoring for nosocomial 
infections to detect transmission pathways of norovirus in a hospital environment. 
Sequencing of the norovirus P2 domain, which is located in the ORF 2 capsid gene, 
was used to link patients with identical strains into clusters (24, 25). This approach 
identified possible clusters that would be missed by standard epidemiological cluster 
analysis.  
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Materials and Methods 
 
Data collection and fecal specimens 
 
Data on norovirus positive cases diagnosed between 2002 and 2007 were retrieved 
from the database of the hospital laboratory and grouped as nosocomial cases, 
outpatient cases and community acquired cases (1). We used a conservative estimate 
to ensure high specificity by considering the possibility of nosocomial transmission 
only  if a patient was diagnosed with NoV infection for the first time  > 4 days after  
admission. Patients tested positive for NoV 0-1 days after admission were defined as 
community acquired cases. Patients with NoV positive stools diagnosed 2-4 days after 
hospitalization were classified as indeterminate. On the basis of the > 4 day cut-off, 
22 nosocomial clusters had previously been obtained using epidemiological criteria 
(defined as ≥2 nosocomially infected patients with NoV on the same ward within 5 
days) (1).  Background data listing age, sex of patient, ward where the patient was 
hospitalised, date of hospitalisation, and date of onset of diarrhoea were drawn from 
the hospital database. This extraction was done by an authorised person, who also 
anonymized the records prior to use by the research team, in compliance with 
regulations on use of patient data.  
 
 
Outline 
 
Stored fecal specimens (stored at -80°C) were retrieved, viral RNA was extracted and 
strains were typed using a two-step approach: first, viruses were assigned to a 
genotype by sequencing region A of the polymerase gene (22). Subsequently the 
corresponding P2 domains in the capsid gene were sequenced, with a specific P2 
primer set for each genotype (24). This approach was necessary because the genetic 
diversity of noroviruses P2 regions is so high that a single set of primers has inherent 
low sensitivity.  
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RNA Extraction and RT-Reaction 
 
Faecal samples were suspended (200 mg/ 200 µl in Hanks’ medium (800 µl) 
containing penicillin, and clarified for 30 minutes at 3000 rpm/ 4°C (8000 rcf, 
eppendorf 4515 R) 200 µl of the supernatant was transferred to the Magna Pure LC 
plate for RT-PCR (program: total nucleic acid extraction, according to the 
manufacturer’s instruction; MagNaPureLC) with an elution volume of 50 µl (Roche 
Diagnostics GmbH).  For genotyping, 20 µl RNA extract was reverse transcribed to 
cDNA with random hexamers using the MultiScribe™ Reverse Transcriptase kit 
(Applied Biosystems) according to the manufacturer’s instructions. All the obtained 
CT values in our study correspond with the Real-Time PCR as previously mentioned 
(1). 
 
Genotyping and P2 domain sequencing 
 
A semi-nested PCR was performed on the polymerase region (region A) to type the NoV 
strains. First round PCR reactions were performed with the primer set FW-JV12 
(ATACCACTATGATGCAGATTA) and COGREV (TCGACGCCATCTTCATTCACA)) 
(10), 10 µl cDNA was added to 40 µl mix/ reaction, containing 5 µl PCR buffer, 1 µl FW/ 
REV primer (70 pmol), 2 µl MgCl2, 29.5 µl Adest, 1 µl DNTP’s (10 mM), 0.5 µl Hotstart 
Taq polymerase (2 Units).  The 2nd round PCR reaction (semi nested) was performed with 
primers set JV12-FW and JV15-REV (CTCATCCAYCTRAACATNGNYTCYTG). Two µl 
of the 1st PCR product was added to 48 µl mix/ reaction, containing 5 µl PCR buffer, 1 µl 
FW/ REV primer (70 pmol), 2 µl MgCl2, 37.5 µl Adest, 1 µl DNTP’s (10 mM), 0.5 µl 
Hotstart Taq polymerase ( 2 Units). Both PCR’s were performed using Gene Amp 9700 
(Applied biosystems, USA) with the following cycling conditions: 96 °C for 15 min, (1 cycle) 
96 °C, 52 °C, 72 °C each 1 min for (40cycles), 72 °C for 10 min). PCR products were loaded 
on 2% agarose gels (stained with syber safe). When the target band was observed (approx 650 
bp), the PCR products were purified with ExoSAP-IT (USB corporation, USA Cleveland 
Ohio) (2 µl ExoSAP-IT - 5 µl PCR product) followed by sequencing with the same primers 
(used for PCR)  using ABI Prism BigDye Terminator 3.1 approach (Applied Biosystem 3730 
DNA Analyzer); denaturation 96°C for 10 sec, 96 °C -10 sec, 50 °C -5 sec and 60 °C- 4 min 
(25 cycles). After assignment of genotype, type specific primers were used to sequence a 794-
818 nt target covering the P2 domain (24). This was done only for the two most common 
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genotypes GII.3 and GII.4 for which sufficient background data was available for 
sequence similarity comparisons. Primers and PCR conditions were as described (24).  
 
 
Sequence analysis 
 
The obtained sequences were entered and aligned in Bionumerics (software package 
5.1, Applied Maths), and typed with a genotyping tool for noroviruses (URL: 
http://www.rivm.nl/mpf/norovirus/typingtool). The sequences were connected with 
the available background data file listing age, sampling date, date of discharge from 
the hospital and location (ward) where the patient stayed while hospitalized. (19). The 
P2 domain sequences with an average length of nt 550 were compared using the 
Neighbor Joining method (TREECON for Windows) to identify patients that had 
identical sequences in order to create molecular clustering. Sets of identical sequences 
were defined as clusters (Figure 1). The community acquired cases served not only as 
background sequence data in the comparison but were also used to link with 
nosocomial cases in order to detect introduction of strains into the hospital.  
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A)GII.4 
 
 
 
 
 
 
 
 
 
 
 
02-2720|O|1|02-12-31
03-360|C|1|03-02-16
05-220|E|50|05-01-20
07-2341|N|0|07-08-27
06-985|K|14|06-03-21
07-4114|M|3|07-04-27
04-2639|O|1|04-12-26
05-982|J|0|05-04-01
07-003356|V|1|07-12-27
06-2699|D|0|06-10-23
07-3254|W|1|07-12-17
03-704/825|E|7|03-03-24
05-58|O|4|05-01-06
05-3007|K|0|05-12-08
05-464|S|10|05-02-14
06-1826|A|12|06-07-03
05-2957|O|30|05-12-05
06-2815|J|0|06-11-07
07-211|G|0|07-01-21
07-1198|I|4|07-04-10
07-19|B|12|07-01-01
07-759|E|12|07-03-06
07-719|F|6|07-03-01
06-1788|H|7|06-06-23
06-1700|A|22|06-06-09
06-3110|K|1|06-12-12
06-2412|A|42|06-09-25
07-403|L|1|07-02-05
06-3251|C|1|06-12-25
06-3066|F|0|06-12-07
06-2879|A|5|06-11-15
05-002951|O|38|05-12-02
05-10843|O|7|05-12-06
05-246|E|5|05-01-24
05-207|C|17|05-01-20
05-368|A|2|05-02-01
05-131|Q|1|05-01-13
05-797/960|R|3|05-03-14
04-002363|K|0|04-12-02
05-14|T|7|04-12-24
04-2652|C|0|04-12-27
07-3366|U|2|07-12-27
07-3347|U|9|07-12-27
07-3327|Y|0|07-12-23
07-3321|G|0|07-12-22
03-628|F|11|03-03-14
03-470|F|0|03-02-27
100
88
100
100
91
98
94
100
99
94
83
100
99
81
75
91
100
99
90
94
100
Scale 0.1
9
6
8
1
4
5
3
2
7
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B)GII.3 
 
 
 
Fig 1. legend A) & B). Phylogenetic trees representing the clusters (1 to 14) of GII.4 (A) and GII.3 (B) 
strains from both community-acquired and nosocomial cases detected in hospitalized patients. Each 
strain is labeled as follows: SS-TTTT_U_V_WW-XX-YY, where SS is the year, TTTT is the unique 
case code, U identifies the ward, V is the number of days after admission at the time of diagnosis, and 
WW (year)-XX (month)-YY (day) is the sampling date. Strains from patients who were not 
hospitalized but were sampled while visiting the outpatient clinic or emergency department are 
indicated with a V of 0. 
 
 
 
 
 
 
 
03-0480|R|8|03-02-28
03-2605|C|5|03-11-10
07-2008|D|0|07-07-10
07-1428|G|0|07-04-27
07-1290|C|6|07-04-14
07-3063|D|0|07-11-26
07-2400|C|49|07-09-03
07-2181|G|0|07-07-31
06-2799|M|112|06-11-06
07-0291|A1|6|07-01-29
07-2369|C|135|07-08-31
07-2624|G|0|07-10-03
07-0510|C|7|07-02-13
06-0824|M|66|06-03-08
07-2216|C|12|07-08-04
07-0326|C|10|07-01-30
07-2320|C|8|07-08-22
06-0473|G|0|06-02-08
06-2710|C|12|06-10-24
07-0282|C|2|07-01-27
07-2355|H|54|07-08-29
07-2326|Z|82|07-08-23
07-0563|C|20|07-02-16
07-0496|C|92|07-02-10
07-1189|R|104|07-04-07
07-1107|B1|56|07-04-03
06-2665|C|7|06-10-23
06-2662|C|12|06-10-23
06-2652|C|11|06-10-20
06-2647|C|4|06-10-19
06-0206|L|0|06-01-16
06-0080|L|3|06-01-05
100
100
95
79
77
100
91
94
98
88
84
96
82
78
Scale 0.1
10
13
14
12
11
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Statistical analysis 
 
To test for differences in proportion of nosocomial infection, the following steps were 
taken. First, the proportion of nosocomial cases within all cases (based on the cut-off: 
onset of norovirus illness > 4 days after admission) was calculated for the genotype 
categories GII.4, GII.7, GII.3, remaining genotypes (rest), and unknown. These were 
calculated separately for the young children (0-5 years) and the remainder (>5 years), 
as young children potentially are at increased risk for norovirus infection and 
therefore virus introduction into a hospital is more common for this age group. In 
these calculations, we excluded cases who had been diagnosed between 2 and 4 days 
after hospitalizations, as the distinction between hospital-acquired and community 
acquired infection is not always possible (n=44). Secondly, using the Chi-Square test 
of independence, we tested whether the proportion of nosocomial infection was 
independent of (a) genotype, within each age group, (b) age, within each genotype, (c) 
genotype, within all ages and (d) age, within all ages. Because we were testing 
multiple hypotheses (nine in total), we needed to adjust the Chi-Square p-values to 
control for false discoveries. We use the Benjamini-Hochberg method here, as this 
method has more power than other Bonferroni-type procedures (2). A relationship 
was considered significant if the adjusted p-value did not exceed 0.05. 
 
 
Results 
 
In total, 264 patients (out of n = 2458 that were evaluated) had tested positive for 
noroviruses during the 5 year period. Of these, 61 % of the infecting strains (n=160) 
could be genotyped. Viruses belonging to GII.3 (34%, n = 54), and GII.4 (51%, n = 
82) were most commonly identified, followed by viruses of GII.7 (9%, n=15), GII.2 
(4%, n=6) and GI.6B/ II.17 (2%, n=3). The samples that could not be genotyped were 
retested using different diagnostic PCR’s. Mean CT values did not differ between 
samples that could or could not be genotyped.  
Overall, 48 % (n=128) of NoV positive patients most likely had hospital acquired 
infection according to the cut-off. Newly diagnosed cases 17 % (n=44) had onset of 
illness within 2-4 days after admission, but their exact source of infection could not be 
established. Finally, 35 % (n=92) tested NoV positive 0-1 day after admission and 
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were classified as community cases. In Table 1 the proportion of nosocomial cases for 
several groups based on age and genotype is shown. These proportions vary from zero 
(for GII.7 strains in adults) to 0.737 (for GII.3 strains in children below 5 years of 
age). As shown in table 1, genotype GII.3 in children showed a high proportion of 
nosocomial infections, whereas in the age group > 5 this was the case for GII.4 strains 
(Table 2). Testing the relationship between the proportion of nosocomial transmission 
and genotypes on one hand, and age on the other hand showed that the proportion of 
nosocomial transmission was significantly different in the older age group, but not in 
children. Overall, nosocomial NoV was more commonly observed in young children. 
Viruses of genotype II.3 were more often found in young children. 
 
 
 
 
Table 1. Proportion of nosocomial infection by age and genotype
a
.  
Group  Genotype Age Proportion of 
Nosocomial infection 
No. of 
Patients 
1 II.7 0-5 0.286 7 
2 II.7 Rest 0.000 6 
3 II.4 0-5 0.478 23 
4 II.4 Rest 0.553 47 
5 II.3
 
 0-5   0.737 38 
6 II.3 Rest   0.143 7 
7 Unknown 0-5 0.688 48 
8 Unknown Rest 0.694 36 
9 Rest 0-5 0.500 6 
10 Rest Rest 0.000 2 
A All genotypes 0-5 0.631 122 
B All genotypes Rest 0.531 98 
C II.7 All ages 0.154 13 
D II.4 All ages 0.529 70 
E II.3 All ages 0.644 45 
F Unknown All ages 0.690 84 
G Rest All ages 0.375 8 
 
a 
Groups are defined as any combination of age group and genotype. Patients who tested positive for 
NoV after 2 to 4 days of admission were classified as indeterminate and were omitted from the analysis 
(n = 44). 
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Table 2. Results of testing the relationship between the proportion of nosocomial transmission and 
genotypes or age.  
 
 
Within subgroup Null Hypothesis             Adjusted P-value 
        
Significant 
    
0-5 year old Independent of Genotype 0.14  
>5 years old Independent of Genotype <0.01 Yes 
GII.7 Independent of Age 0.69  
GII.4 Independent of Age 0.69  
GII.3 Independent of Age 0.02 Yes 
Unknown Independent of Age >0.99  
Rest Independent of Age 0.60  
All ages Independent of Genotype <0.01 Yes 
All genotypes Independent of Age 0.30  
 
 
 
Molecular clustering 
Based on clustering of cases in time and place (two or more cases on the same ward 
within a five day interval) 22 clusters had previously been identified in the original 
dataset (1). Viruses from the two major genotypes of NoV (GII.4 and GII.3) were 
further analyzed. Sequence comparison of amplified P2 domains showed nine clusters 
of GII.4 strains involving 17 different patients and five clusters of GII.3 strains 
involving 8 different patients (Figure 1 and Table 3).  Of the molecular clusters, three 
(two GII.3 and one GII.4) had previously been identified through epidemiological 
observation as shown in table 3.  The other 11 identified clusters of patients had not 
previously been identified as such. This was explained by the fact that all clusters 
included patients from different wards and ages. Remarkably, for 5 patients this 
included a link with a patient that had visited the hospital outpatient care department 
but was not admitted (clusters 3, 6, 9, 10 and 14)  
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Discussion  
We describe results of a systematic evaluation of patients diagnosed with NoV in a 
large hospital between 2002 and 2007, to look for evidence of nosocomial outbreaks 
through sequence based clustering of cases. This approach was done as part of a study 
aimed at mapping the sources of virus introduction that may be amenable to 
intervention strategies, as NoV outbreaks in hospitals may have significant health 
impact.  The use of sequence analysis in this study identified 11 clusters that had not 
been recognized through earlier defined epidemiological clustering (1), increasing the 
number of probable nosocomial clusters by 50 %. Almost half of these involved links 
with a patient that had visited the hospital but was not admitted, suggesting 
introduction of virus into wards through staff movement or contaminated surfaces.  As 
we used a rather conservative cut-off for the definition of nosocomial infection, we 
may have underestimated the prevalence. 
 
 
Table 3. Overview of molecular clustering versus epidemiological clustering 
Molecular 
clusters  
Presence of 
epidemiological 
clusters  
 
Ward (s) Presence 
within  
5 days 
No. of 
nosocomial 
infections 
No. of 
indeterminate 
Cases 
No. of 
community
-acquired 
cases 
1 NO Different Yes 2 0 0 
2 NO Different NO 2 0 0 
3 NO Different NO 1 0 1 
4 YES Same Yes 3 0 0 
5 NO Different Yes 2 0 0 
6 NO Different Yes 1 0 1 
7 NO Same Yes 1 1 0 
8 NO Different Yes 0 0 2 
9 NO Different NO 2 0 1 
10 NO Different NO 1 0 1 
11 NO Different NO 3 1 0 
12 YES
*
 Same Yes 2 0 0 
13 YES
*
 Same Yes 4 1 0 
14 NO Same NO 0 1 1 
 
*
Cluster identified by both methods, but the size (number of patients) differed 
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We analysed the virus diversity in relation to date of hospitalisation. This provided the 
opportunity to compare diversity of the viruses in nosocomial patients with that of the 
viruses causing illness in the community. This comparison is essential, as widespread 
community outbreaks may occur in which case finding identical sequence in the 
hospital may not signify a hospital acquired event. An example where this occurred is 
cluster 8 in Fig. 1 (A), showing 2 apparently connected patients with community 
acquired illness. However, as all other community acquired cases were distinct, this 
strengthened the support for the observed approach and thus the clusters that were 
identified.Our findings clearly show the limitations of the commonly used 
epidemiological clustering, where these clusters would not be noticed. Here, patients 
are identified as possible linked cases when they have been hospitalised within the 
same wards and within the same time frame (5 days).   
A limitation in our study is the number of samples for which genotype could not be 
determined. As mean CT’s did not differ between stool samples with and without a 
genotyping result, quantity of virus in the original specimens is not an explanation. A 
reasonable explanation could be the different PCR’s used for diagnosis and 
genotyping: the former uses a smaller amplicon size and fragmentation of RNA 
during preparation and freeze-thawing could preferentially influence the genotyping 
PCR with its longer target fragment. Alternatively, it is possible that the non-typeable 
samples contain different norovirus genotypes, but we could not find any evidence for 
that.  
In the current approach, we used a stringent selection based on 100 % similarity 
among strains as defining a link (24, 25). This may be too stringent, as NoV is rapidly 
evolving, and mutations are accumulated rapidly (20). Therefore, allowing one or 
even two nucleotide differences between sequences could potentially increase the 
sensitivity of outbreak detection. However, this remains to be proven, as few studies 
have addressed the evolution of NoV over different chains of transmission (3, 20).  
Interestingly, we found that the proportion of nosocomial infections seems to depend 
on the particular strain involved. In particular the GII.3 strains showed a significantly 
higher proportion of nosocomial infection regardless of age compared to the other 
genotypes. This illustrates the complexity of NoV epidemiology, showing that NoV 
should not be viewed as “a” virus, but rather as a group of related viruses with 
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different properties. This comes as no surprise given the huge diversity of NoV: 
viruses belonging to GII7 and GII.4 are quite distinct. Taking these differences into 
account, one could possibly speculate that each specific genotype could be associated 
with a particular disease burden. As shown within the family Picornaviridae, another 
family of positive stranded RNA viruses, genetically related viruses can cause a quite 
distinct spectrum of diseases (13). In addition to the virus genotype, age group needs 
to be factored in:  the GII.3 strains are found more often in children and in nosocomial 
cases, compared with GII.4 for which this age difference was not found.  
Our findings suggest either differences in susceptibility or severity of GII.3 in 
different age groups, as has been described for group A rotaviruses (16). A plausible 
explanation would be the development of herd immunity, given the widespread 
circulation of these viruses. For GII.4, rapid evolution of viruses into new antigenic 
variants has been shown to be an explanation for the repeated epidemics involving all 
age groups (14).   
The age related probability of transmission in a healthcare setting is something to be 
aware of. The generally higher rate of nosocomial infection in the young is easily 
explained by the hygienic conditions: young children may wear diapers and the 
handling thereof is associated with higher exposure to stools.  Without proper hand 
washing hygiene, this may constitute a greater risk of transmission. A second factor 
could be that viral loads are higher in young children as has been observed for other 
viruses in which immunity develops. Be it as it may, non-viral factors, such as 
behavior (e.g. hygiene) seem to be an important factor contributing to transmission. 
In conclusion, we show the usefulness of molecular information as basis for detecting 
transmission events in the hospital setting. We show that the use of molecular typing 
may increase the early detection of clusters by 50 %, and were able to identify 
introductions from the outpatient department. This indicates that a careful review of 
movements of people between outpatient clinics and wards could potentially identify 
areas for improvement. The significantly increased proportion of nosocomial 
transmission of GII.4 and GII.3 strains compared with that of other NoV belonging to 
other genotypes shows that an early warning system that identifies increasing 
prevalence of new variants of these genotypes rapidly could be used to guide 
enhanced infection control policies.   
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Nosocomial transmission of norovirus is 
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Abstract 
 
Background. Nosocomial norovirus (NoV) infection is common and may increase 
the burden of disease in health care settings, particularly in vulnerable hospitalized 
patients. Implementing effective infection control during and after admission may 
limit further spread, but evidence based measures are lacking.  
Methods. In this study we performed a systematic evaluation of sources and modes of 
transmission during norovirus outbreaks within two types of healthcare facilities. An 
outbreak protocol was developed to sample all patients and healthcare workers 
(HCW) with and without symptoms on wards involved in outbreaks. Data on clinical 
history and possible high risk exposures were collected. Five outbreaks were 
investigated, involving 28 patients with recognized symptomatic norovirus infection.  
Results. Enhanced sampling, however, yielded 65 additional cases, of whom 14 % 
(n=9) were asymptomatic patients, 57 % (n=37) symptomatic HCW, 17 % (n=11) 
asymptomatic HCW. For 12 % (n = 8), clinical data were not provided (2 HCW and 6 
patients). On the basis of the shedding kinetics, the onset of infection was estimated 
for each case. The generation interval was then used to construct plausible 
transmission pathways and reproduction numbers for symptomatic and asymptomatic 
patients and HCW.  
Conclusion. We found that symptomatic patients and HCW were more often involved 
in transmission events than asymptomatic shedders. Asymptomatic HCW rarely 
contributed to transmission, despite high levels of fecal virus shedding.  
 
 
Key words: nosocomial transmission, symptomatic shedders 
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Introduction 
 
Norovirus (NoV) is the most common cause of acute gastroenteritis worldwide [1]. 
Transmission of NoV most often occurs through direct contact with NoV shedders, or 
indirectly through environmental or food contamination with human feces or vomit, 
especially in closed settings such as hospitals, nursing homes, cruise ships and hotels 
[2-4]. In a previous study we demonstrated the high transmissibility of NoV in a large 
tertiary care hospital, resulting in frequent nosocomial outbreaks [5]. Transmission 
from chronic patients shedding NoV for a long period of time may also occur, as we 
have demonstrated previously [6].  
 
There are few examples of contribution of asymptomatic shedders to (nosocomial) 
outbreaks [7, 8], although several publications have reported the high prevalence of 
asymptomatic shedding [9-12]. In adult volunteer studies, 32 % (13 of 41) of infected 
persons remained asymptomatic after challenge with Norwalk virus [13, 14], but this 
involves persons with good general health and a rare genotype, not representative for 
the hospitalized group of patients. Systematic studies addressing the role of 
asymptomatic carriage of NoV and its implications in these settings are lacking. 
Implementation of stringent infection control measures is recommended to control 
outbreaks but scientific evidence underpinning these measures is missing [15]. One of 
the most frequently asked questions is when an infected healthcare worker (HCW) 
can return to work, particularly because people may shed NoV for several days and 
even weeks after recovery [16, 17]. In the present study we have investigated the 
contribution of symptomatic and asymptomatic patients and HCWs to transmission 
based on data collected during in depth investigation of three NoV GII.4 outbreaks in 
three separate healthcare settings. The onset of shedding was estimated from shedding 
patterns using a nonlinear regression model, and the results were used to identify 
plausible transmission patterns. This analysis strongly suggests that most transmission 
is caused by symptomatic shedders, and that asymptomatic NoV positive healthcare 
workers only minimally contribute to the spread of infection in an outbreak setting. 
We also conclude that there is substantial underdiagnosis of NoV infection in HCW 
and that these undetected infections may contribute substantially to outbreaks, 
particularly when they are symptomatic.  
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Methods 
 
We developed an enhanced outbreak investigation protocol focusing on the 
identification of possible sources and modes of transmission of NoV within a tertiary 
care hospital and 2 nursing homes in the region of Rotterdam (Netherlands) between 
January 2009 and March 2010. Directors or chiefs from centers reporting 2 or more 
cases of NoV confirmed by polymerase chain reaction (PCR) within the same ward 
within the same week were asked to participate in this study. The study protocol 
included random sampling irrespective of symptoms of all patients and HCWs on 
affected wards using a strict protocol as is done for methicillin-resistant 
Staphylococcus aureus [18]. Persons involved in the outbreaks who met the inclusion 
criteria of the study protocol were tested weekly until a negative test was returned. 
Measured virus concentrations (cycle threshold/ CT measurements) in the feacal 
samples were used to calculate the most probable first day of shedding by means of 
regression analysis. Details are provided in the appendix. With the onsets of shedding 
known for all sampled subjects, serial intervals between all pairs of infected subjects 
could be calculated. Subsequently, we computed the probability of transmission 
between any pair of cases by using the distribution of serial intervals as described 
previously [19]. With this transmission matrix, reproduction numbers were estimated 
for symptomatic and asymptomatic patients and/or HCW.  
 
The study was done in one academic hospital, and two nursing homes covered by the 
municipal health service of Rotterdam-Rijnmond. An outbreak was defined as two or 
more cases of patients or HCW in the same department with gastroenteritis symptoms 
within 24 hours. Gastroenteritis was defined as diarrhea and/or vomiting (two or more 
episodes within 24 hours) that could not be attributed to underlying illness, or 
medication. 
The duration of each outbreak was defined as the period starting seven days before the 
start of symptoms of the index case and lasting until seven days after the start of 
symptoms of the last case. For this period, all patients and HCW involved with the 
care and treatment of patients, or using a shared toilet in the treatment facility or 
healthcare unit were approached for participation. Patients who had been discharged 
within the seven days before the onset of illness in the first recognized case were not 
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approached. Children up to 18 years of age and participants with a legal representative 
could be included in the study after authorization of their parents and/or legal 
representative.  
Each person who consented to participation in this study was provided with a stool 
sampling kit and a small questionnaire aimed to consider their clinical state. 
Quantitative reverse transcription-PCR and genotyping of the strains were performed 
as previously described [5].  Persons with NoV positive stool specimens were asked 
to resend a specimen once a week until they tested negative.  
 
 
Data analysis 
 
Estimation of onset of excretion in asymptomatic cases 
 
In order to calculate likely transmission patterns, an estimate of the onset of 
infectiousness is needed for each case. In previous studies using only symptomatic 
cases, this has been assumed to be the date of illness onset [19], but this approach can 
not be used for the asymptomatic shedders. Therefore, we estimated the first day of 
shedding from the time course (increase followed by decrease) of virus excretion 
using stool sample data that were available for both asymptomatic and symptomatic 
cases. A parametric model of virus shedding was used, based on a compartment 
model of virus production and excretion in the intestinal tract (“Appendix”). After 
transformation to –log scale (to accommodate for CT measurements as obtained by 
real time PCR analysis) the model was fitted in a two-level Bayesian framework, 
allowing for variation in time course (rates of increase and decrease) and amplitude 
(peak level of virus excretion) among individual shedders. Onset of shedding, 
measured as time from the first sample, was included as a covariable that could be 
estimated for both symptomatic and asymptomatic shedders. More details of the 
model and parameter estimation are available in the “Appendix”.  
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Transmission Patterns 
 
With the estimated onsets of shedding, asymptomatic cases could be added to the 
dataset, extending the epidemic curve. With the help of the serial interval distribution 
(defined as the distribution of time between onsets of shedding in successive 
symptomatic or asymptomatic cases) the onset dates may then be used to estimate the 
likelihood of transmission between any pairs of cases, as reported previously [20]. 
Different outbreaks were treated as separate (isolated) clusters, and no transmission 
was assumed to occur between cases infected with different genotypes. In contrast to 
patients, the HCW cannot be assumed to be in continuous contact with hospitalized 
patients or nursing home residents. To adjust for contact time, the transmission 
probabilities of HCW were weighted by the fraction of the time they were present 
(typically 8 of 24 hours). No difference in prior weighting was applied for 
symptomatic/asymptomatic cases. Pairwise probabilities of transmission (the elements 
of the transmission matrix) were estimated by Markov chain Monte Carlo sampling, 
as reported previously [19], resulting in a Monte Carlo sample of matrices with 
elements representing the probabilities of transmission from any subject (i) to any 
other subject (j).  
 
Different iterations of this matrix were used to obtain uncertainty estimates for any of 
the selected output metrics. Initial parameter values for the serial interval distribution 
were taken from a previous  study [19]: a gamma distribution with parameters (shape 
parameter 3.35, scale parameter 1.09, leading to a mean serial interval of 3.6 days, 
and mode (most likely interval) 2.6 days). As soon as convergence was reached, 
adjustment of the serial interval distribution was allowed by updating its parameters, 
followed by optimization of the transmission matrix until (again) convergence. This 
nested approach resulted in improved estimates (higher posterior probability) with 
slightly shorter estimates of the serial interval compared with its initial value.  
 
 
Transmission by category  
 
The number of infections caused by any subject i was estimated by summing over all 
cases j the probability that j was infected by i [20]. This is defined as the reproduction 
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number of subject i. Thus transmission among and between patients and HCWs, and 
from patients to HCWs and the reverse, were calculated as reproduction numbers of 
these categories for each of the outbreaks. We further stratified the analysis by type of 
symptoms, differentiating between cases with diarrhea and cases with vomiting 
 
 
Results 
 
Outbreak analysis 
 
From January 2009 until March 2010, five outbreaks were reported caused by three 
different NoV genotypes i.e. GII.4, GII.2 and GII.7. One cluster (OB 1) was 
segregated by use of molecular typing, into 2 groups of patients infected with GII.4 
2008 (n= 18) and GII.4 2006b (n = 4), respectively (Table 1). Because the GII.b strain 
sequences were diverse, these patients were excluded from the group as likely new 
introductions unrelated to the outbreak. Full details of this outbreak will be published 
elsewhere. All the other outbreaks consisted of a single genotype. The duration of the 
outbreaks ranged from 38 days to 77 days. Outbreaks (OB) 1, 2 and 3 were detected 
in the hospital, whereas 4 and 5 occurred in nursing homes. In total 386 HCW and 
127 patients/residents were approached for participation, and 257 (66 %) of the HCW 
(range 60-72 %) and 79 (77 %) of the patients/residents (range 68-100 %) agreed to 
take part in the study.  In total, 50 (20 %) of participating HCW had at least one 
positive stool (PCR), and 43 (54 %) of participating patients were tested positive. 
Details on testing results are listed in table 1.  The enhanced case finding resulted in a 
276 % (n=69) increase in total number of subjects with confirmed NoV infection, 
assuming that typically only symptomatic NoV in patients/ residents are reported, as 
has been detected in the routine diagnostics. The shedders that were symptomatic 
detected in each OB were as follows: OB 1 (n=16), OB 2 (n=6), OB 3 (n=8), OB 4 
(n=18) and OB 5 (n=17). Of the additionally diagnosed shedders, 29 % (n=20) did not 
report any symptom. 
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Modeling  
 
The analyses described below were done only for the GII.4 outbreaks (OBs 1, 4 and 
5), because transmission patterns may differ for viruses belonging to different 
genotypes, thus precluding pooling of all data [5, 6]. GII.4 strains are predominant in 
outbreaks in healthcare settings [21]. The same serial interval distribution was used 
for all outbreaks, because there is no information at this point about the heterogeneity 
in serial intervals among NoV GII.4 variants. The shedding kinetics of all the cases 
involved in the GII.4 outbreaks was used to estimate onsets of shedding. Transmission 
analysis produced adjusted estimates of the serial interval distribution, and estimates 
of the probability of transmission between any pairs of cases in the studied outbreaks.  
An example of a transmission tree derived from the transmission matrix iteration with 
the highest posterior probability (as approximation of the posterior mode) is shown in 
Figure 1.  
 
 
 
 
 
 
Figure 1: Example of a plausible transmission tree for one of the outbreaks (OB5), based on outcome 
of markov chain monte carlo as described in the ''Methods'' section. Patients/residents (P) and 
healthcare workers (H) are shown, symptomatic cases are indicated in black characters, and the 
asymptomatic cases are shown as gray characters 
 
 
Delta t (onset illness- sampling) in days 
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The Monte Carlo estimates for the probability of transmissions by any infected 
subject were used to calculate their individual reproduction numbers and these could 
be averaged by category, stratifying cases by symptom status for NoV infected 
persons for all cases without diarrhea (white boxes; Figure 2 left panel) this resulted 
in an average reproduction number of 0.85 (95% confidence interval 0.55-1.05). And 
for all cases with diarrhea (grey boxes; Figure 2, left panel) this resulted in an average 
reproduction number of 1.64 (95% confidence interval 1.56-1.70). This shows that the 
contribution of asymptomatic shedders to transmission was significantly lower than 
that of symptomatic individuals when data from all outbreaks were combined, 
although the pattern differed between outbreaks: in outbreak 4, the difference in 
contribution to transmission from asymptomatic cases was not significantly lower. 
Next, we stratified the data for patients and HCW (Figure 2, right panel). For the 
symptomatic patients this resulted in an average reproduction number of 1.89 (95% 
confidence interval 1.71-2.12). And for the symptomatic HCW this resulted in an 
average reproduction number of 1.30 (95% confidence interval 1.08-1.52). While for 
the asymptomatic HCW no reproduction numbers could be detected.  This result 
shows that the difference was greatest for the HCW, where contribution to spread by 
asymptomatic persons could not be detected, and for symptomatic HCW this was 
significantly lower than for symptomatic patients. Asymptomatic patients did 
contribute to transmission, but less than persons with symptomatic infection.  
7
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Conclusions and discussion 
 
In this study, we performed structured outbreak investigations with enhanced 
sampling following after notification of a suspected outbreak, to obtain data that can 
be used to design evidence based strategies for prevention of spread of NoV in 
healthcare settings. We have seen that enhanced sampling yielded a 232 % increase of 
identified shedders consisting of asymptomatic patients and HCW, and symptomatic 
HCW that normally would be missed in the routine sampling. These results illustrate 
the potential underestimation of the size and duration of an outbreak in regular 
outbreak investigations where sampling of HCW with health complaints is not done 
routinely, and sampling to identify asymptomatic shedders is rare.  
HCW in general have been presumed to play a role in transmission, because their 
work involves direct contact with many patients. We used the enhanced surveillance 
data to address the question of who contributes most to shedding. Persons infected 
with NoV may continue to shed high amounts of virus for several weeks after 
resolution of symptoms [5, 6, 22], and hospital hygienists or persons working in the 
food industry need to decide whether it is safe to return to work. The current Center 
for Infectious Disease guideline recommends that people should not resume work 
until 2-3 days after clinical recovery, but evidence for this is lacking and the extra 
leave of absence may be problematic in small food establishments or health care 
settings during peak seasons. Therefore, we tried to determine who contributes most 
to the spread of infection, and whether this was related to being symptomatic.  
Our findings clearly suggest that symptomatic shedders are more frequently involved 
in transmission than asymptomatic shedders. No transmission was observed from 
asymptomatic HCW, despite considerable levels of virus shedding in the stool. This 
shows that an infected person does not need to be infectious, most likely related to 
proper personal hygiene. The latter is indicated by the difference between HCW and 
patients with NoV: there was a significant difference in the contribution of HCW to 
transmission both for symptomatic and asymptomatic shedders, and the awareness of 
HCW of the need for hygiene would be the most likely explanation for this difference. 
For instance, proper hand hygiene can lower the incidence of NoV [23], although 
overall evidence for effects of hand hygiene on prevention of healthcare associated 
infections is considered to be weak [24]. Nevertheless, our observations suggest that a 
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more important factor is the health status. Our study did not reveal differences 
between persons with vomiting and persons with diarrhea in their contribution to 
spread of infection, as is frequently suggested. This may be related to the power of the 
study, and should ideally have been addressed in more extensive studies. However, 
these studies are difficult to conduct, because the occurrence of outbreaks cannot be 
planned, and willingness to participate in studies is influenced by the extra work 
needed in patient care during outbreaks. Based on these findings, we conclude that the 
period of mandatory leave from work for infected HCW potentially may be relaxed. 
However, this conclusion relies on unbiased reporting of illness episodes by HCW, 
which may be overly optimistic. In a study of self compliance during a NoV outbreak, 
it was found that a quarter of affected personnel did not adhere to quarantine 
recommendations [25].   
Illness reports from hospitalized patients and from HCW are often done through 
different reporting channels (for instance the hospital hygiene department and the 
office of personnel), although the combination of observations would enhance the 
early detection of outbreaks.  Our study shows that notified cases in an outbreak may 
be the proverbial tip of the iceberg, and increased awareness is warranted.  
Even with enhanced sampling there is still evidence of under ascertainment: of the 
HCW that did agree to participate, 13% of those that tested negative for NoV did have 
symptoms compatible with acute NoV infection. There are several possible 
explanations why no virus was found. Sampling of these cases may have been too 
late, so that virus excretion may have decreased to undetectable levels [16]. In 
addition, HCWs may be capable of early clearance of the virus due to their better 
immunity status compared with hospitalized patients [26]. Therefore, we compared 
the results with and without the NoV negative HCW with diarrhea.  Adding them to 
the transmission analysis produced similar results for the distributions of reproduction 
numbers in different subject categories (as in Figure 2, results not shown). 
An important factor that was not included in our study and may influence the 
construction of transmission trees is the role of environmental contamination. This is a 
potential source of protracted outbreaks, as has been documented in multiple outbreak 
reports [27-30]. In our approach, we disregarded this option, by assuming relatively 
short intervals between consecutive cases, based on distribution of generation 
intervals observed during person to person outbreaks. In the outbreaks studied here, 
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we believe that environmental persistence did not play a major role, because the 
observed generation intervals plotted based on the dates of onset of new cases did not 
differ significantly from the distribution observed during a model outbreak [19]. Of 
course, this cannot be taken as a generalization, because situations may differ between 
hospitals and healthcare settings, resulting in vast differences in the likelihood of 
environmental contamination [27, 30, 31].  
To our knowledge, this is the first time estimates of the first day shedding of 
asymptomatic cases with NoV have been made. Virus excretion patterns were only 
used for determining the onset of shedding in symptomatic and asymptomatic 
shedders. As a further refinement it is tempting to use other aspects of the excretion 
patterns, such as duration of shedding and the peak levels of excreted virus, as proxies 
for the infectivity of individual cases. In a subsequent study we plan to enhance the 
transmission analysis method to incorporate these additional information sources, 
allowing for individual differences in infectivity to improve the identification of likely 
transmission pairs.  
To conclude, effective guidelines are needed for diagnostics that includes HCW and 
contacts of positive cases (enhanced screening). Awareness of reporting symptoms by 
the HCW and patients is still an important element for rapid outbreak detection to 
possibly achieve timely intervention. 
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Chapter 5 
 
Shedding of norovirus in symptomatic 
and asymptomatic infections. 
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Abstract 
Background and methods. Enhanced surveillance for studies of transmission of 
norovirus in hospital outbreaks has yielded a considerable number of asymptomatic 
shedders. Fecal samples from symptomatic and asymptomatic infections were 
analyzed by real–time PCR. To study norovirus shedding a quantitative dynamic 
model was fitted to the shedding data from 102 subjects, in a multilevel Bayesian 
framework.  
Results. The results indicate that shedding in asymptomatic cases is similar to that in 
symptomatic infections, both showing considerable variation in peak levels (average 
10
5
 – 109 per g feces) as well as the duration of virus shedding (average 8 – 60 days). 
Patients appear to shed higher numbers of virus than staff, for slightly longer 
durations, but the differences are too small to be significant.  
Conslusion. The results are of interest for studies of norovirus transmission, 
specifically studies that need to quantify the deposition of virus in the environment.  
Keywords: norovirus, shedding, asymptomatic infection, viral gastroenteritis, 
quantitative PCR  
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Introduction 
Viral gastro–enteritis is an important concern for public health and a major cost factor 
for society. Hospitals and nursing homes are affected in particular [1, 2]. The 
epidemic potential of norovirus is striking [3, 4] and has been partly attributed to its 
high infectivity [5]. There is no clinical treatment for norovirus disease, or a vaccine 
that protects against infection, although clinical trials are ongoing [6]. Hygiene 
measures and quarantining of cases are therefore currently the only option for 
containing an outbreak [1, 4]. Norovirus is transmitted via the fecal–oral route: 
primary food– or waterborne cases may shed virus into their environment. Virus 
deposited on surfaces can then cause outbreaks [7, 8] and virus can be transferred by 
hand contact [9] followed by ingestion [10]. In order to better understand how much 
virus is deposited in the environment, we have studied virus shedding in infected 
subjects.  
A human challenge study has shown that there may be considerable heterogeneity in 
the numbers of viruses that are shed by infected subjects [11]. Generalization of the 
results from this study to nosocomial outbreaks raises uncertainty because of study 
size (16 subjects) and the use of experimental infections, with a Norwalk virus (GI.I) 
inoculum in healthy volunteers [12].  
For the present study into shedding of norovirus during nosocomial transmission, 
patients with symptoms of acute norovirus infection as well as any known contacts 
were asked to submit fecal samples that were analyzed by quantitative RT–PCR for 
the presence of norovirus [13, 14].  
 
Materials and methods 
Data 
Four distinct outbreaks of gastro–enteritis caused by norovirus GII.4 were detected by 
prospective monitoring during the winters of 2009–2011, in a tertiary care hospital 
and three nursing homes [14]. Upon detection of outbreaks of two or more PCR 
confirmed cases in the same ward, data were collected from as many patients and 
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health care workers as possible, with or without symptoms of norovirus gastroenteritis 
[14]. Fecal samples were collected from all subjects who gave consent and these were 
followed up weekly, until they tested negative for norovirus.  
Virus concentrations were measured by quantitative (real time) RT–PCR. Details 
about sample collection and preparation, and assay performance have been published 
[15]. For any sample a single Ct value was always measured.  
Four NoV GII.4 outbreaks studied in the winters of 2009 – 2011 were selected for 
further analysis, yielding a total of 230 fecal samples in 102 (out of a total of 125) 
subjects. Of these, 47 were patients (32 with symptoms, 15 asymptomatic) and 55 
health care workers (39 with symptoms, 16 asymptomatic). There were also 23 
subjects (6 patients and 17 health care workers) with symptoms of gastroenteritis who 
did not consent to collection of samples.  
 
Model for the time course of virus shedding 
A realistic model of the time course of virus shedding must include an initial increase 
in virus concentration, followed by a decrease to undetectable levels. For virus 
produced at an infection site and transported by bowel movement, the observed virus 
concentration in feces can be written as  
 
(1) 
At onset of shedding (t = 0) the virus concentration C(t) increases from 0 (with rate 
C0(β - α)), reaches a maximum and decreases to zero (with rate α). More details, as 
well as a tentative biological mechanism, are given in the online appendix, section A.  
Assuming the parameters (C0,α,β) vary among individual infected subjects, this model 
can be applied in a Bayesian hierarchical framework [16].This results in individual 
estimates of the time course of virus shedding, with the variation among these 
individuals characterized by (joint) probability distributions of the parameters of the 
regression model (equation 1). All models were run in JAGS (v 3.3.0) [17] using rjags 
(v 3-10) [18] in R (v 3.0.1) [19]. Due to censoring tests of model fit using the DIC 
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cannot be used, but in a (separately provided) supplemental file the reader can check 
that the model accurately fits the observed Ct data. Figure A1b in the appendix shows 
residuals for all observed Ct values in all subjects.  
The onset of shedding (t = 0 in equation 1) cannot be observed. For symptomatic 
subjects the onset of symptoms may be assumed to occur shortly after the onset of 
shedding [14]. For asymptomatic subjects an estimate of the onset of shedding may be 
found that provides the best agreement of the observed virus titres with the time 
course of equation 1. This has been achieved by expressing time of onset of shedding 
relative to the first fecal sample that was collected, and treating the delay between 
onset and first sample as a parameter that can be estimated. Technical details of this 
procedure are given in the online appendix, section B. For the symptomatic subjects 
the estimates of shedding onset agreed well with the observed symptom onsets, as 
shown in the online appendix of [14].  
 
Calibration curve 
To obtain a titration curve a standard suspension was made of RNA prepared as run–
off transcript from cloned fragments (GII.4 Bristol region B, junction ORF I and II). 
To avoid inhibition on the target RNA, yeast tRNA was added that competitively can 
react with the RNase. For quality control a dilution series in yeast tRNA was included 
until 10
-15
. The number of genome copies in an undiluted PCR sample of that 
suspension can be calculated from the RNA concentration measured by Nano Drop 
(ND–1000 ISOGEN Life Science) as follows: an equivalent volume of 0.33 μl (2/15 × 
2.5μl) of the RNA solution contains 2279 ng/μl RNA, with 1684 nucleotides (MW ≈ 
1684×320 +159 =539.04 kD). The concentration of genome copies in undiluted 
suspension then is  
 
where NAv is Avogadro’s number (6.02214×10
23
). Tenfold serial dilutions of this 
standard suspension were used for obtaining a calibration series of Ct values.  
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A calibration curve, obtained by linear regression, allows translation of observed 
Ct values in fecal samples into numbers of genome copies of NoV (GII.4). In the 
regression procedure, Ct values of 40 were considered censored (Ct ≥ 40). Figure A1c 
shows the regression curve with (95% ) prediction intervals. A Monte Carlo sample of 
the estimated parameters of this regression model was used to translate Ct estimates 
into virus concentrations, incorporating measurement error due to translation.  
 
Results 
Fecal samples containing norovirus were obtained from 71 symptomatic and 31 
asymptomatic subjects. Numbers of patients/staff and their age ranges are given in 
Table 1.  
 
 
 
Total  Symptomatic Asymptomatic 
 
number  number  age (mean, 95% range)  number  age (mean, 95% range)  
patients 54  32  81.6 (50.6 – 93.6)  15  80.4 (55.8 – 94.2)  
staff 47  38  40.7 (18.2 – 61.3)  16  35.0 (18.9 – 53.2)  
 
Table I: Numbers of infected patients and staff sampled for norovirus shedding, by symptoms, 
and their ages (mean age in years and 95% range). 
    
Using the date of the first fecal sample as a reference, estimates of the period Δtpred 
were obtained: the time between onset of shedding and the first sample. In 
symptomatic cases with fecal samples present there is good agreement between Δtpred 
and observed times between the onset of symptoms and the first sample, indicating 
that symptoms tend to appear within a day after the start of virus shedding.  
In asymptomatic subjects the onset of symptoms is missing, and the fitting procedure 
thus produces estimates of the onset of shedding, based on observed virus shedding 
patterns [14].  
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Figure 1: Time course of virus shedding in symptomatic and asymptomatic subjects. Median and 95% 
interval of the predicted virus concentration (10 log numbers of viruses per g stool) are shown 
 
Figure 1 shows predicted levels of virus shedding as a function of time, in 
symptomatic and asymptomatic subjects. More details are given in the online 
appendix ; fitted responses for all individuals can be provided in a separate document.  
For ease of interpretation, instead of rates of increase and decrease the time from 
onset of shedding to peak levels and the duration of shedding (time from onset of 
shedding to decline to Ct = 40, considered the diagnostic detection limit) can be 
calculated (Figure 2b,c). In addition, the peak levels of virus shed (Figure 2a) and the 
total amount of virus (area under the shedding curve) can be calculated (Figure 2d).  
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Figure 2: Characteristics of virus shedding for patients and staff: estimated means of (a) peak levels of 
shedded virus (10 log number of viruses/g stool), (b) time from onset of shedding to peak in virus 
shedding (days), (c) total duration of the shedding period (days) and (d) the estimated total amount of 
virus shed (area under the shedding curve, 10 log numbers of viruses/g stool). Means of Monte Carlo 
samples of (posterior) values, for staff and patients, symptomatic and asymptomatic. 
 
There is an indication that patients, in particular when they have symptoms, may shed 
higher levels of norovirus, for somewhat longer periods (Figure 2). Note however that 
Figure 2 shows the variation in individual means of predicted characteristics: when 
uncertainty is taken into account the differences are very small (see p–levels in Table 
A2 in the appendix).  
The posterior distributions of these characteristics also do not indicate a substantial 
difference between symptomatic and asymptomatic subjects. There is however 
considerable uncertainty, as illustrated in the individual estimates in Figure 3.  
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Figure 3: Characteristics of virus shedding vs. age of individuals: estimated individual (a) peak levels 
of shedded virus (10 log numbers of viruses/g stool), (b) time from onset of shedding to peak in virus 
shedding (days), (c) total duration of the shedding period (days) and (d) the estimated total amount of 
virus shed (area under the shedding curve 10 log numbers of viruses/g stool). Monte Carlo sample of 
(posterior) values with mean and uncertainty (95% credible intervals), for symptomatic (black) and 
asymptomatic (grey) subjects. 
 
 
 
None of the four characteristics of the time course of shedding (peak levels, time to 
peak, duration of shedding and total excreted virus) appears to depend on age of the 
infected subjects (Figure 3). Estimated time to peak and durations of shedding show 
positive correlation (Pearson correlation coefficient 0.873 and 0.973 for symptomatic 
and asymptomatic subjects, respectively), as do peak levels and total amount shed 
(correlation coefficient 0.960). For additional details see the appendix (Table A1).  
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Discussion 
Norovirus is transmitted fecal–orally: its high infectivity and persistence in the 
environment allow the virus to exploit various pathways. Norovirus present on 
fomites is considered to be important for transmission [10]. Such virus can be 
deposited by infected subjects, via contaminated hands [9]. As a potential driver for 
the numbers of viruses that are deposited by infected subjects, the concentration of 
virus shed in feces is of interest. A study of virus shed by volunteers challenged with 
Norwalk virus (GI.1) showed considerable variation in the numbers of viruses in 
stools of infected subjects [11]. Another study of nosocomial norovirus infection in 
aged–care facilities showed a range of concentrations and durations of shedding [20].  
The present study comprises a larger number of subjects than previous studies, 
including some with asymptomatic infections, sampled in the course of a study on 
nosocomial transmission of norovirus in the Netherlands [14]. Patterns and quantities 
of shedding in infected symptomatic and asymptomatic subjects are remarkably 
similar. The variation in peak levels among individual subjects is large, with 
minimum as low as few hundreds of virus genomes per g, and maximum (95%–ile 
predicted concentration) above 10
10
 virus genomes per g feces. The peak excretion 
levels are in the same range as those reported by [20], and slightly lower than those 
reported by [11]. It remains unknown whether the difference may be attributed to the 
different genotype (GI.I) used in the latter study.  
The rates of increase and, more importantly, decrease of virus shedding are also 
variable, but to a lesser extent. In infected subjects shedding has dropped to low levels 
(less than 10
3
 viruses/g) by day 60 post infection. As symptoms usually do not last 
longer than 2 weeks the contribution of such long lasting shedding to transmission 
may remain small [14].  
In a study among hospitalized patients more serious symptoms (longer duration) were 
associated with higher virus concentrations [21]. In the study reported here such an 
association was not apparent, in fact, symptomatic subjects seem to shed norovirus in 
similar numbers as asymptomatic subjects (Figures 3a and 3d), while both categories 
show considerable variation (mean peak levels of excreted virus/g stool vary over a 
range of ≈ 4 10 log units).  
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One may be tempted to interpret the shedded numbers of viruses as an indicator for 
the intensity of infection, with higher numbers corresponding to more infected cells in 
the intestinal mucosa. If that is true, the variation in numbers shed may not have great 
clinical significance because shedding appears equally intense in symptomatic and 
asymptomatic infections. Staff, either symptomatic or asymptomatic, seems to shed 
higher levels of norovirus than patients, for a longer period. However, the difference 
is small and insignificant against the large variability in responses (Table A2 in the 
appendix).  
Also worthy of note is that a transmission study in the same cohort has shown that 
symptomatic cases (staff and even more so patients) are more likely to transmit the 
virus than asymptomatic shedders [14]. As asymptomatic shedders appear to produce 
equal numbers of viruses as symptomatic cases, this difference in transmission must 
be attributed to enhanced environmental seeding of the virus, associated with 
vomiting and diarrhea.  
It is likely that only a part of the excreted virus genomes is in infectious virus 
particles, as has been observed for other viruses [22–24]. Assuming that the fraction 
infectious virus does not depend on the level of shedding (the peak concentration), 
this large variation may imply that different infected subjects may shed very different 
numbers of infectious noroviruses into their environment, and consequently they may 
have considerably different infectiousness to their contacts.  
The present study is part of a greater project aimed at quantifying nosocomial 
transmission of norovirus in hospital and care facilities. It will be interesting to use the 
individual shedding patterns as a proxy for the infectiousness of each subject, 
allowing adjustment of the contribution of any individual to transmission according to 
the numbers of viruses they excrete at any time following infection [4, 14, 25]. Such 
an individual–based approach may considerably improve the faithfulness of tracking 
of infections during an outbreak [26]. Direct use of the estimated virus concentrations 
to predict risk of transmission from individual infectious subjects seems attractive. It 
must however be realized that at present little is known quantitatively about the role 
of human behavior both in spreading shedded virus in the environment and in picking 
up that virus from contaminated fomites.  
89 
 
Conclusions 
During norovirus infection, high numbers of virus are shed in feces. Numbers of 
viruses in feces increase rapidly, reaching peak levels within a few days following 
onset of infection, followed by a slow decline for several weeks. It may take more 
than two months until fecal concentrations of virus reach undetectable levels. Both 
peak levels and duration of shedding show considerable individual variation that is 
not different between symptomatic and asymptomatic infections.  
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Abstract  
 
Background. Norovirus P2 domain is commonly used to extrapolate transmission 
within an outbreak (OB) setting. The current definition is that transmission among 
cases is considered to be proven when no sequence variation is found. 
Objectives. Previous studies have shown a high mutation rate and errors during 
replication of the norovirus genome, therefore the validity of this criterion must be 
evaluated. 
Study design. Sequences of the P2 domain were obtained from patients and health 
care workers sampled during 4 prospectively GII.4 outbreaks. Faecal samples were 
tested by RT-PCR for presence of norovirus RNA against a standard control 
preparation to allow quantification. Estimated time of onset of shedding was derived 
from shedding kinetics modelled on data from sequential sampling. Thereby P2 
sequence variation could be linked to estimated total virus excretion in individual 
subjects. 
Results. In all the outbreaks, P2 domain variation was found that resulted in unique 
codon changes in some patients. Mutations were found in 14% of initial samples and 
> 50% of follow-up samples taken from patients involved in an outbreak. In three 
patients, aa mutations was observed in or near sites involved in host or antigen 
binding.    
Conclusions. We concluded that P2 domain variation increases with duration of virus 
shedding, but was unrelated to total amounts of virus shed. Therefore, we propose that 
cluster identification based on identical sequences should be relaxed to accommodate 
minor sequence variation. When using sequence data to support outbreak 
investigations, sequence diversity should be interpreted in relation to timing of 
sampling since onset of illness. 
 
Keywords: norovirus transmission, shedding, P2 domain 
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Background 
 
Noroviruses (NoV) are a major cause of gastroenteritis worldwide and are most 
commonly associated with outbreaks in health care settings 
1
. Onward transmission of 
noroviruses is common when guidelines for outbreak control are not applied 
rigorously 
2
. For developing effective control measures, a proper understanding of the 
transmission patterns during outbreaks is needed, including the role of healthcare 
workers and asymptomatic shedders. Molecular typing of NoV-positive stool samples 
can be used to determine links between individual cases. A systematic analysis of 
genome diversity in a large dataset collected through the Food-borne viruses of 
Europe network concluded that the optimal target for sequence-based linking of cases 
was the capsid gene 
3
. For practical reasons, currently the P2 domain of the NoV is 
used 
4, 5, 6, 7
. This genome region is considered to be the most variable part of the 
genome since it codes for the protruding domain of the capsid protein, which contains 
the receptor binding domain and important epitopes targeted by antibodies that inhibit 
binding 
8, 9
. In GII.4 NoV, the P2 domain evolves by accumulation of mutations under 
selective pressure from host immunity 
10, 11, 12
. Accumulation of mutations in this 
domain was also shown in immunocompromised patients with prolonged shedding of 
viruses 
13
. Recently the use of next generation sequencing identified minority variants 
present during transmission events 
14
.   
 
 
Objectives 
 
P2 domain sequencing has been used for identifying the transmission pathways and 
links during outbreaks 
4-7
 and identical P2 domain sequences are considered evidence 
for a cluster. However, with the high mutation rate of norovirus 
15
, nucleotide changes 
may occur within a short time interval, raising the question what would be an 
appropriate minimum number of nucleotide changes for defining a cluster of cases 
connected by direct transmission links. This question is relevant because outbreaks 
may be missed with common cluster detection algorithms that use time and space, or 
pseudo-outbreaks may occur when many patients are hospitalized during peak season 
6, 7
. Therefore, we set out to quantify P2 domain variation, during four prospectively 
monitored outbreaks in three nursing homes and a tertiary care hospital 
16
. We 
96 
 
sampled NoV-positive patients and health care workers (HCW), identified through an 
enhanced outbreak protocol irrespective of their symptom status. Variation in 
sequence data between and within outbreaks, as well as variation between and within 
infected subjects was analyzed and correlated with the estimated number of viruses 
shed by each individual. The results can be used to redefine criteria for linking of 
cases to outbreaks.  
 
 
Study design 
 
We prospectively monitored four GII.4 outbreaks starting from January 2009 until 
March 2011 in the region of Rotterdam in the University Hospital (EMC) and in 
nursing homes 
16
. Sampling was based on an enhanced outbreak investigation 
protocol focusing on the identification of possible sources and modes of transmission 
of NoV 
16
. The study protocol included random sampling irrespective of symptoms of 
all patients and HCW on affected wards with NoV. Patients and their contacts 
involved in the outbreaks who met the inclusion criteria of the study protocol were 
tested weekly until a negative test was returned. Each case was confirmed by 
sequencing region A (genotyping) followed by P2 domain sequencing 
6, 17
. The 
amount of virus shed by each subject was estimated from real time RT-PCR analysis 
of all fecal samples, using RNA transcribed from a plasmid containing a sequence 
spanning all commonly used diagnostic targets as a reference template 
18
, allowing us 
to investigate correlation between virus excretion and P2 domain changes over time. 
Background sequences from the same geographic region were collected from patients 
 
 
Sequence analysis 
 
RNA fragments were reverse transcribed with random hexamers (Invitrogen), 
yielding cDNA that was amplified by a nested PCR and subsequently sequenced 
using the ABI-PrismBigDye Terminator v3.0 Ready Reaction Cycle kit. The same 
primers were used for amplification and sequencing the P2 domain (primers 1
st
 PCR: 
F: 5’gangatgtcttcacagtctctt ‘3, R: 5’cattcctgggggagtagaca ‘3 4, Nested primers: F: 5’ 
gtgccacccacagttgag ‘3, R: 5’gggagtagacagtccaa ‘3). DNA Sequences were entered and 
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assembled in bionumerics 6.6.2 (Applied Maths, Sint-Martens-Latem, Belgium) and 
evaluated manually for their quality by looking for the number of ambiguities, errors, 
mismatches and deletions. 
Sequences were aligned; genotype and variant assignment was based on the RdRp region 
16
 
using the norovirus typing tool (http://www.rivm.nl/mpf/norovirus/typingtool; 
19
. Full-length 
P2 domain sequences (600 nucleotide) were then subjected to pairwise analysis (UPGMA) to 
identify strains linked to the same outbreak, and by advanced cluster analysis 
(maximum parsimony), to compare diversity within and between outbreaks and 
robustness of clustering. Sequence diversity within patient and between patients 
within an outbreak was assessed by comparing the minimum and maximum number 
of mismatches for each outbreak separately. Translated sequences were reviewed to 
look for possible directional amino acid mutations.  
 
 
Sampling and virus shedding 
 
To study the effect of sampling delay, the time of onset of shedding was estimated by 
extrapolation from modelled shedding kinetics, based on data from all subjects with 
follow up samples (Teunis et al, submitted). An RNA standard template was used to 
translate CT values in fecal samples into an estimated viral load. PCR based estimates 
of NoV shedding were then used to calculate total numbers of viruses shed by 
sampled subjects, allowing analysis of sequence variation against viral load, clinical 
symptoms (symptomatic or asymptomatic), and occupational status (HCW/patients). 
To characterize the rate of sequence variation all data were pooled and the survivor 
function for sequence change was calculated, using a Kaplan-Meijer estimator 
20
 
describing the probability of any nucleotide changes versus time from onset of 
shedding .  
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Results 
 
Strain typing and clustering 
The four GII.4 outbreaks occurred in 3 nursing homes and 1 university hospital. The 
ages of the included HCW/ patients from the hospital setting ranged from 25-77 and 
54-77 years, respectively. In the nursing homes, ages for the residents were high (72-
95 years), while for the HCW this ranged from 20-63 years. Details of the outbreaks 
have been described elsewhere (15). In total 175 HCW and 77 patients consented to 
enhanced case finding, of which 50 HCW and 47 patients tested positive for NoV 
infection (Table 1).  Capsid gene sequencing was successful in 109 NoV positive 
stool samples from a total of 252 sampled cases, comprising 44 HCW and 37 patients 
16
. OB 4 yielded 48 sampled cases but the data is not published yet. Failed sequences 
were repeatedly tested but persistently failed to produce sequence information. The 
success of sequencing was unrelated to the levels of virus shedding (data not shown). 
Phylogenetic analysis of all P2 domain sequences showed a clear discrimination of 
the four GII.4 outbreak clusters, but with mixed results for OB 1: here, the outbreak 
strains segregated into three different clusters: GII.4 2008 (17 cases) and 2 clusters 
belonging to the GII.4 2006b variant lineage (2 cases each), (Figure 1).  As this 
suggests that a minority of the patients was from a different, unrelated cluster, detailed 
molecular analysis was not performed for these strains. Data retrieved from the 
hospital database showed that one of the samples belongs to a nurse who was 
involved in patient interviews. The other three subjects were patients who had been 
admitted into the hospital. From the epidemiological data, it was clear that one patient 
developed diarrhea after admission, indicating a nosocomial infection.  
 
Comparison of these results against the strain diversity observed in the background 
dataset (defined as sequences from patients admitted with norovirus infection) showed 
that these were unique and distinct from the outbreak sequences with few exceptions 
(4 %), (Figure 1). In OB 4 a unique single case was observed who showed at least 15 
nucleotide differences compared to the outbreak strain, suggestive for an unrelated 
introduction. 
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Within and between patient sequence diversity  
 
The percentage nucleotide diversity based on P2 domain analysis (600 base pairs) 
between outbreaks (OBs) including all samples ranged from 6.3- 7.3 % of sequences 
different at genotype level, and from 0.7- 1.2 % at variant level. Sequence variation 
within outbreaks was small (0 – 0.3%) and overlapped with sequence diversity within 
subjects (0- 0.3 %).  At the time of first sampling 70 (86 %) persons of OB 1-4 (both 
patients and HCW) had an identical sequence, designated the outbreak strain  
consensus, whereas 6 (38 %) were shedding a virus with a single nucleotide change in 
the first sample and one person had a sequence with 2 nucleotide changes shortly after 
onset of shedding. During follow-up, more nucleotide changes were seen; in total 56 
% of follow-up samples tested yielded one or more mutations.  
 
Figure 2 shows the timing of sampling in relation to the estimated period of shedding, 
as estimated from the kinetics of shedding as described elsewhere (Teunis et al., 
submitted). The sampling delay ranged from 0-23 days for symptomatic cases with a 
median of 8.5 days since the estimated time of infection, and 3-7 days with a median 
of 5.4 days for asymptomatic cases.  
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When summarizing the rate of sequence change in a Kaplan Meier plot, sequence 
changes appeared from 4 days post onset of shedding. The rate of increase in 
probability of a sequence change indicates that for samples collected at three weeks 
post onset of shedding there is a 10% probability of (1-2) nucleotide changes (Figure 
3). 
 
 
      
 
 
 
 
        
 
 
 
When the shedding data were combined with the sequence data no significant 
association could be seen between shedding and virus excretion or sequence variation, 
although patients seemed to excrete slightly higher numbers of viruses than HCWs, 
for a longer period (Figure 4).  
 
 
 
 
Figure 3: Sequence changes Y-as (S/ 100 %) over time after onset of shedding X-as (days), shown by 
nonparametric (Kaplan-Meier) estimate of the probability of sequence change calculated for the 
complete set of infected subjects from all four outbreaks (mean curve and 95% range). 
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Codon changes 
 
In total, 11 nucleotide changes resulted in codon changes (6 in HCW, 5 in patients). 
Codon changes were observed in OB’s 2 and 3 only. In these outbreaks, almost all 
nucleotide sequence changes (8 out of 10 and 3 out of 3, respectively) were codon 
changes.  Six of the amino acid changes were located at positions in the P2 domain 
that have been identified as informative sites, because they were one of the marker 
mutations for global variants of GII.4 (S255G, S310R, T340A, Y352H, S393N, 
K248R) 
11, 12, 21, 22
. Amino acid changes at positions A256T and N373S were seen 
sporadically in the past, as illustrated in figure 5 (Genbank accession numbers). The 
remaining amino acid changes were unique, located at the following sites; D312N, 
D312E, R411K. One of the mutations was located in the histo-bloodgroup antigen-
binding site (position 393), one in a position that was resulted in an additional RGD 
motif on the GII4 2002 strains, and one mutation was near epitope A. No pattern of 
amino acid changes was observed to verify transmission between subjects (Figure 5).  
 
                                                                                                         
 
Previously reported outbreaks 
 
Background information from the hospital and the nursing homes with OB 1, OB 2, 
OB 3 and OB 4 indicated that no outbreaks had been reported on the same department 
shortly before these outbreaks were identified.  
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Discussion 
 
Molecular analysis can help define transmission pathways during outbreaks, 
particularly when combined with metadata 
5, 6, 17
. For NoV the proposed molecular 
marker is the P2 domain, since this domain is considered hypervariable thus providing 
sufficient resolution for use of sequence data for linking of cases (17). According to 
our results, each outbreak has a unique consensus sequence based on P2 domain 
homology. Phylogenetic analysis of P2 domain sequence data can therefore unravel 
pseudo-outbreaks and specifically can serve to exclude strains that do not belong to 
the outbreak (Figure 1). It can also provide information regarding the extent of the 
outbreak, for instance concurrent sampling from the population extraneous of the 
outbreak can provide additional linked cases based on the P2 domain homology.  
More detailed analysis of the domain revealed that in addition to diversity of the P2 
domain between outbreaks there was minor variation within each outbreak, and 
among follow-up samples from individual patients and HCW. Most of the samples 
were collected between 4 and7 days of post onset illness when the transmission was 
most intense; however, the majority of the NT changes occurred in a later stage (Fig 
2).  In the outbreaks studied here, the variation within the P2 domain does not exceed 
2 nucleotide changes and therefore a maximum number of nucleotide changes of 0.33 
%/ 600 bp is a conservative threshold to suspect a new introduction. The time interval 
to the first sequence change can be relevant for future outbreak investigations, with 
changes observed as early as 4 days following infection.  
 
The position of each nucleotide change was unique and was only found in single cases 
with one exception. This suggests that minor sequence changes during NoV outbreaks 
are a random phenomenon in otherwise healthy individuals. However, an indication of 
immune driven selection is the finding that the majority of mutations in follow-up 
samples were codon changes, with two remarkable mutations: mutations in position 
393 have been associated with alterations in histo-bloodgroup antigen binding 
patterns of GII.4 strains 
23
, and therefore such strains potentially could target a 
different segment of the population. One mutation was at a position adjacent to 
epitope A (position 373) and therefore potentially influencing antibody binding.  
Amino acid changes at position 340 have been found in almost all GII4 variant 
transitions, and therefore may be significant as well 
12, 21, 22
. While speculative, this  
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suggests that new variants may arise quite rapidly in patients during the course of a 
single infection. Still, an antibody response has to be mounted after an infection since 
we do not know the exposure history of the individuals involved. Although all of them 
were adults and therefore most likely had experienced multiple norovirus infections 
prior to the present one, given the high incidence of these infections in the population 
24
.  
 Obviously, more information is needed to define transition to a new (epidemic) 
variant. In our study, we found no evidence of onward transmission of the viruses 
with potentially informative mutations. Without changes, affecting transmissibility 
such variants would most likely not emerge as major strains, given the omnipresence 
of competing strains circulating in the general population. This may be different when 
such infections occur outside the norovirus winter season, and a question is whether 
chronic norovirus infection in immune-compromised individuals could serve as a 
reservoir for new variants 
13
.  
 
Finally, the sequence variations observed in the present study demonstrate the need to 
reconsider the guidelines 
4-7
 for identifying clusters: the currently used cut-off of 100 
% identical P2 domain sequence should be relaxed to allow minor variations, thereby 
potentially increasing the attribution of cases in health care settings. Conversely, since 
the variation in the P2 domain is limited within the same cluster, it is often difficult to 
trace transmission events using only sequence data, particularly for defining 
transmission between individual infected subjects. We have established that the 
resolution is insufficient to conclusively identify links between individuals within 
outbreaks (who infected whom): for such purposes, more enhanced sequencing or 
sequencing of a larger part of the genome is required by considering the presence of 
minority variants/ quasi species.  
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Figure 5. Amino acid (AA) changes (informative sites) in P2 domain sequences of GGII.4 outbreak 
strains collected between 2009 and 2010. The informative sites throughout the protein are listed 
from left to right. AA numbering is indicated at the top, and names are given on the left. From top to 
bottom, blue color indicates identical amino acids, and overlapping AA of the background 
(Genbank accession numbers) are illustrated in brown and distinct AA with yellow. The red colors 
indicate the locations of insertions of the GGII.4 strains during the OB’s.  Sequences in the middle 
area (brown) are reference GII4 strains Symbol (-) indicates failure of partial sequence. 
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Abstract 
 
Background. Noroviruses cause acute gastro-enteritis with a high rate of secondary 
transmission, resulting in outbreaks particularly in healthcare settings and elderly 
homes. Understanding sources of introduction of these viruses may provide clues for 
control. Here, we set out to find possible sources of introduction by combining 
questionnaire information with analysis of transmission patterns through laboratory 
and clinical reports.  
Methods. From 2009 until 2011, 7 norovirus OB were investigated through an 
enhanced outbreak investigation protocol, where questionnaires were administered for 
each infected subject identified through random sampling of symptomatic and 
asymptomatic cases. The most likely index cases were identified by calculating 
transmission trees combining data on onset of illness, virus shedding, and from spatial 
information. The possible source of infection was assessed through review of 
questionnaires for these cases.  
Results. The outbreaks differed in size (19-43 cases) and duration (1 – 3 weeks).  In 
total, 199 persons consented to participate in the questionnaire survey (99 patients, 
104 HCW). 60% of persons reporting with some symptoms tested positive for 
norovirus, with rates of positivity higher for samples collected on day’s 5-8 post 
illness onset than earlier during the illness. In 4 outbreaks, the index case was a HCW, 
but 3 of these mentioned contact with a symptomatic person at work, suggesting 
missed cases. One outbreak most likely was patient indexed, and two outbreaks 
remained unresolved due to lack of information.  
Conclusions. Despite extensive investigation, it proved difficult to identify sources of 
introduction of norovirus in the majority of outbreaks, and index cases most likely 
were missed in three of the outbreaks. The lower rate of PCR positivity of cases with 
recent onset of illness potentially contributes to underestimating extent of spread.   
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Introduction  
 
Norovirus is a highly contagious virus, causing outbreaks of gastroenteritis worldwide 
in all age groups. Norovirus infection can be quite disruptive, causing considerable 
disease burden, especially in infants and the elderly [1].  Transmission of norovirus is 
common and outbreaks are often seen to occur in crowded environments like cruise 
ships, hospitals, nursing homes [2-8]. Usually the sources of outbreaks remain unclear 
[9]. In recent years, guidelines have been developed to target community acquired and 
nosocomial transmission of norovirus in health care settings, focusing on reducing 
onward spread [7]. Despite existing regulations and applications of different protocols 
to reduce transmission, there is still a need to identify sources of outbreaks [7, 10, 11]. 
How and when infectious subjects introduce the virus often remains unclear due to 
lack of detailed molecular and epidemiological information. In outbreak studies, 
questionnaires have been useful for collecting demographics, understanding of 
possible sources, behavior of subjects, introduction of the virus, and details pertaining 
to transmission patterns [12, 13]. Here, we present results from enhanced outbreak 
investigation for 7 outbreaks in the region of Rotterdam. Enhanced case finding was 
done by sampling of all persons involved (possibly in contact with a symptomatic 
case and those who consented to participate), and repeated testing of all NoV positive 
cases [8, 14]. A simultaneously deployed questionnaire survey was developed to 
complement the previously published information for 4 outbreaks, to query additional 
information about possible modes of transmission of NoV in these settings and to 
provide a standardized case history that systematically assesses possible sources 
(patients, personnel, visitors, environment, and food).  
 
Materials and Methods 
 
Set up of the study 
 
During 2009 until 2011, 7 outbreaks have been monitored prospectively, 4 in nursing 
homes and 3 in the Erasmus Medical Centre, all in the region of Rotterdam (the 
Netherlands). A systematic sampling protocol was designed, in which patients and 
HCW were requested to fill out a questionnaire and to provide a weekly stool 
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specimen starting within one week of first notification of a case. On a weekly basis, 
anyone who had a positive stool sample was approached with an additional short 
questionnaire focusing on contact with symptomatic cases, in an attempt to verify 
(confirm or exclude) potential onward transmission of the virus. This protocol was 
continued until a negative sample was returned. Cases that tested negative and had no 
symptoms were not followed up and excluded from the study.  
Positive samples were characterized by analysis of the capsid gene sequence (P2 
domain). Sequences were aligned with the past 4 global epidemic, and with sequences 
from all norovirus positive cases diagnosed in the past 11 years in the same hospital to 
confirm or rule out clustering [7]. The main questionnaire included a standardized 
case history, systematically assessing potential sources (patients, HCWs, visitors, 
environment, food), and probable transmission routes (person to person, contaminated 
food, contact with vomitus/ faeces) while additional questionnaires for individual 
cases queried basic information e.g. age, onset date of illness and also addressed 
illness in (household) contacts who were asked to provide a stool specimen. Upon 
inclusion, each patient or HCW in this study was assigned a unique anonymized 
identifier code.  NoV outbreaks that were notified when they involved patients 
(through the hospital infection prevention department) or illness reports from staff 
(occupational health) were treated uniformly, and one designated team member (a 
research nurse) contacted the hospital ward to explain the set-up of the study and 
interview patients and staff.  The study protocol was subjected to the medical ethical 
committee of Erasmus MC, and was approved. 
 
 
Assessment of the questionnaires 
 
Everyone who consented to participate in the study was approached to complete the 
questionnaire, however less than 50 % of the questionnaires were returned (in some 
cases only partially completed). Details on illness onset or estimated timing of onset 
of shedding were used to identify most likely index cases and their contacts [15]. 
Review of the questionnaires from these individuals focused on possible transmission 
routes and potential sources of infection. Any recorded information of interventions 
aimed at interrupting or reducing transmission, e.g. disinfection, cleaning and 
quarantine, was collected, and the timing of these interventions was compared to the 
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epidemic curve for each outbreak. A qualitative assessment of knowledge and 
attitudes of HCW and patients towards hygiene measures was done through face-to-
face interviews by the research nurse.   
 
Quantitative virus detection and genotyping 
 
To evaluate whether cases with symptoms of gastroenteritis that tested negative for 
NoV resulted from sampling too late or too early after onset of symptoms, all the 
outbreak data were pooled and the sampling delay (from illness onset) was calculated. 
Transmission of norovirus during each outbreak was characterized as described 
previously, constructing transmission networks based on serial intervals between 
cases [8], using estimated shedding patterns of each case (Teunis et al. submitted). 
These transmission networks were confirmed by similarity in molecular sequence of 
the viruses shed by these cases [14]. Transmission analyses allow estimation of the 
reproduction number for any individual: this is the total number of secondary cases 
caused by that individual subject. 
 
 
Results  
 
General overview and the duration of the outbreaks 
 
Seven outbreaks were investigated. In total, 61-100% of patients / residents agreed to 
participation in the investigation, and 43-63% of HCW. The epidemic curves for each 
outbreak are shown in figure 1, listing the symptomatic and asymptomatic NoV 
positive cases. In addition, we also plotted persons with symptoms consistent with the 
case definition who tested negative (Figure 1 and table 1). Overall, 60% of persons 
reporting with any symptoms tested positive for norovirus. There were no significant 
differences between patients and health care workers, or between persons in hospital 
associated outbreaks and nursing home outbreaks, although the highest proportion 
positives was found in the hospitalized patients reporting health complaints in 
association with an outbreak (85%), and HCW from nursing homes were least often 
NoV positive (50%).  
1
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The proportion of NoV positive persons with symptoms was slightly higher for 
patients/residents (85%) than for HCW (76%), and did not differ significantly 
between settings.   
 The outbreaks had an average duration of 1-3 weeks, (the end of the outbreak is 
represented by application of the rule of 2 incubation periods since the last case with 
symptoms, indicated by grey arrows in figure 1). However, outside this stringent 
criterion there were still sporadic outliers with 100 % similar sequence in OB 1,5 and 
6 (*not for all outliers sequencing was successful). Outbreaks in nursing homes had 
higher numbers of cases (mean nr positives 20 for hospital outbreaks versus 35 for 
nursing home outbreaks), (Table 1).  
 
 
Table 1. Overview symptomatic & asymptomatic patients/ HCW versus positive/ negative 
 
 
OB Setting Patiënts HCW Total 
  S+* S- AS+ S+* S- AS+ S+* S- AS+ 
1 H 5 0 0 11 4 4 16 4 4 
2 H 6 2 2 0 9 0 6 11 2 
3 H 1 1 0 7 7 0 8 8 0 
4 NH 7 9 1 11 8 3 18 17 4 
5 NH 9 2 6 8 6 4 17 8 10 
6 NH 18 14 1 6 4 0 24 18 1 
7 NH 11 0 0 4 4 4 15 4 4 
 
 
* S+ = symptomatic, NoV positive; S- = symptomatic NoV negative; AS+ = asymptomatic, norovirus 
positive 
 
The OB 2 and 3 were also different in the populations affected: OB 2 included only 
patients (adults and infants), and OB 3 included only HCWs and a single patient. In 
OB5 many asymptomatic NoV positive subjects were found, both among patients and 
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HCW. Two of the elderly subjects in OB5 died: the first person died 10 days after the 
start of the outbreak but tested negative for norovirus, while the second patient who 
died 18 days after the start of the outbreak tested positive for NoV.  
  
 
Classification of clusters  
 
Molecular sequencing of positive samples allowed classification of all the outbreaks 
by using the P2 domain as a molecular marker. In OB1, a small cluster of cases 
infected with a different norovirus  was identified that was excluded from the 
analysis, as reported previously [14]. The remaining outbreaks consisted of single 
genotypes, and clusters were identified based on a (threshold) maximum of 2 
nucleotides (NT) difference within outbreaks, based on a full fragment of the P2 
domain (600 NT), thus considering that all the cases were linked [14] , (Including the 
outliers of each outbreak). 
 
 
Control measures and cleaning 
 
According to protocol, as soon as two or more subjects from the same ward tested 
positive for NoV, this was notified as an outbreak, resulting in ward closure and 
quarantine of infected individuals (figure 1, black arrows). Isolation of infected 
individuals was based upon detection of the virus; hygiene interventions (cleaning and 
disinfection of the whole department) were implemented at a later stage (2-4 weeks 
after detection of the first case). Information about hygiene interventions was only 
provided for the nursing home outbreaks. Regular staff was responsible for cleaning. 
During all observed outbreaks, any small accidents involving vomit or diarrhea were 
cleaned up immediately. Cleaning of the department took place approximately 2-3 
weeks after detection of the first case (indicated by the black arrows in figure 1). The 
hospital wards were cleaned by an external company who did not log the exact dates.  
In OB6 and OB7, isolation of infected subjects was challenging because these wards 
housed patients with mental disorders. The patients in OB 4 and OB5 were physically 
disabled and were likely not aware of transmission contacts. Detailed on-site 
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observation revealed potentially unhygienic behavior of patients in all nursing home 
outbreaks (OB 4-7).  
 
 
Sampling delay versus test outcome 
 
A small number of PCR positive samples were retrieved from subjects on the day 
their symptoms started (day 0) consisting of 3 HCW and 4 patients and the negative 
cases (possibly including false negatives) were not included in the study. The majority 
of PCR positive samples were collected around 4-8 days post illness onset, while the 
majority of the negative samples were seen at illness onset, day 0. Overall, 60% of 
samples from symptomatic cases from whom date of illness onset was known tested 
positive, with a lower positivity rate during the first 4 days (50%) compared to days 5-
8 (78%), (p<0.05).  
The CT measurements showed a decrease between day 1- 4 post onset illness 
(increasing viral load), and a light increase over time (stable) and levels off beyond 
day 10. Note that these observations are based on small numbers of positives only 
(figure 2).  
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Sampling delay vs % Positives 
 
 
 
 
Figure 2. Sampling delay: time between onset illness and sampling are represented of 1-7 detected 
outbreaks against % Positives (the total # of cases are indicated on each bar). The majority of the cases 
were tested positive 4-8 days post onset illness. However, after 2 weeks positive cases were still 
detectable sporadically until day 30. With a sampling delay >8 days, a decrease of the number of 
positive subjects was observed.  
 
 
 
Index cases 
 
Transmission trees were used to identify possible index cases [8]. We also included 
persons with symptoms who tested negative in our selection of possible index cases.  
In total, 14 potential index cases were identified, of whom 4 were patients (in 4 
outbreaks), and 10 HCW. Seven persons did not provide a questionnaire. The 
remaining possible index cases indicated that they thought they had contracted illness 
through contact with a case either in the hospital or nursing home (n=4), or at home (n 
= 1). The others did not provide any information indicating a possible source (Table 
2). Based on this information, the most likely source of introduction was a patient or 
relative in 1 outbreak (OB2; the infant who was a likely index had a father who had 
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symptoms of gastroenteritis at the same time). For three outbreaks, based on the 
response of initial cases the index may have been missed, reflecting late detection 
(OB’s 1, 6 and 7). Based on the combined transmission analysis, in OB 4 a HCW 
(dietician) was the most probable source of the introduction of the virus within the 
department. This HCW was the first subject who tested positive for norovirus within 
the affected ward. She visited several wards, as well as other nursing homes in the 
region. In the questionnaire, this person noted being the first person with 
gastroenteritis symptoms in the department, and having household members who had 
experienced similar gastroenteritis symptoms. For OB3 and 5 no information was 
provided due to non-response or incomplete questionnaires. For OB4 and OB5, 
sporadic cases had been observed prior to the index cases, according to department 
logs. In the period before OB 4 and OB 5 were recognized, there had been an 
outbreak of norovirus in a different department in the same institution.  
 
 
Conclusions and discussion 
 
Our results confirm that with currently attainable levels of infection control, norovirus 
transmission in healthcare settings cannot be completely prevented. We believe that 
thorough understanding of the introduction and transmission of the virus can help in 
setting guidelines for effectively reducing the spread of NoV. We have shown that 
transmission analysis including enhanced molecular typing allows unambiguous 
identification of clusters. Combining these transmission studies with questionnaire 
surveys incidentally did augment understanding of how the virus was introduced, but 
proved very challenging. Despite extensive investigation, only in two outbreaks, a 
most probable source of introduction was identified.  The investigation suggested that 
– despite our efforts for enhanced awareness throughout the study, initial cases may 
have been missed, as initial patients for three outbreaks indicated that they had been in 
contact with a symptomatic person at work. As this could be confirmed later by a 
detailed review of the department logs, one of the lessons is to include such review as 
part of outbreak investigations. Currently such context studies are not part of the 
protocol in the participating institutions. Previous studies have demonstrated a diverse 
pattern of index cases: in 30 nosocomial outbreaks with person to person 
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transmission, at least 20 (67 %) had a patient as a likely index case [16]. In another 
recent study, it was concluded that out of 5 nosocomial outbreaks, at least 4 started 
from a patient [17]. However, HCWs introducing norovirus have also been reported 
[16, 18].  We found that enhanced sampling during outbreaks among patients and 
residents almost doubled the number of recognized norovirus infected persons, some 
of whom remained without symptoms. Therefore, a question is how reliably the data 
from standard outbreak investigations may allow identification of defining index 
cases. An aspect that should be considered in transmission studies is the opportunity 
of contact between subjects. As HCWs work in shifts, possibly 8 hours in duration, 
they are available for contacts for about 1/3 of the 24 hours of any day, while patients 
or residents are usually present for the complete 24 hour period [8, 19, 20]. We have 
found that symptomatic cases, particularly patients with diarrhea, cause more 
transmission than asymptomatic HCWs [8]: symptomatic patients often act as key 
transmitters during outbreaks. This is also consistent with reports that the dominant 
route of transmission during outbreaks is patient-to-patient transmission followed by 
patient to HCW transmission [20]. 
Introduction of norovirus into a health care institution may depend on various factors. 
Compared to patients or residents, HCWs have many (more) opportunities to 
introduce or spread the virus: they are usually involved in preparation of foods as well 
as feeding of residents, have physical contacts with excreta and patients, and they visit 
other departments and health care centers. Therefore, they likely occupy a central 
position in the contact network for virus transmission.  Since most norovirus 
outbreaks occur during the winter (the peak season for norovirus outbreaks),  
introduction from the community should be a factor of concern particularly during 
this season.[21]. Once index cases are recognized, special attention should be given to 
the first generation of secondary infections (transmission from the index cases to the 
other subjects), since this is a crucial moment for interruption, and because the first 
week of a norovirus outbreak often shows the highest intensity of transmission [8]. 
For an optimal detection of these cases, results of RT-PCR should be interpreted with 
caution. During our investigation, only 60% of persons reporting symptoms tested 
positive. Although we cannot exclude false attribution of cases to the outbreak, but 
this lack of PCR positives could also point at sensitivity issues.  When reviewing the 
data for persons for whom date of onset was known, we observed that sampling too 
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early during outbreaks may result in negative PCR while targeting sampling between 
5-8 days post onset illness can increase the number of positive results. 
 
A study evaluating effect of control measures implemented during outbreaks in 
nursing homes in The Netherlands found that timeliness of interventions (within 3 
days post first case notification) was the only factor with a notable impact [22]. 
Despite isolation of cases soon after detection of NoV, transmission was still seen in 
the outbreaks studied here, in agreement with published findings [19, 22]. 
Realistically, even if the first case should be identified within a few days, intervention 
would be already too late to completely stop transmission. Therefore, rapid and 
efficient diagnostic testing is important, to routinely survey patients at admission and 
HCW at regular intervals, particularly during the peak season (winter). It is also 
important for infection prevention staff to create awareness among HCWs of their role 
in norovirus introduction and transmission. It is useful to reiterate that even when one 
is too late, quarantining may be applied to prevent the outbreak to grow even further 
beyond affected wards. 
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Abstract 
 
Norovirus infection in immunocompromised patients may lead to prolonged norovirus 
shedding. Here, we demonstrate involvement of three chronic shedders in hospital 
outbreaks. Combined epidemiological and molecular evidence suggests that in one 
case NoV transmission occurred at least 17 days after the first diagnosis.  
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Introduction 
 
Norovirus (NoV) is a leading cause of acute gastro-enteritis affecting people of all age 
groups (1, 3). Outbreaks with NoV occur often and worldwide (7). In the Netherlands, 
large numbers of outbreaks are reported each winter, particularly from health care 
institutions (6). In a systematic evaluation of newly diagnosed patients with norovirus 
in a large tertiary care hospital, we found that nosocomial norovirus transmission is 
common, and may lead to chronic infection, disease and shedding in at least 6% of 
patients (1). The case histories of the chronic patients showed various underlying 
illnesses resulting in impaired immunity followed by prolonged NoV shedding, in 
some cases for periods longer than 1 year (5). The question arose whether these 
chronic shedders were possible sources for nosocomial infections within the hospital 
setting, also after they had been infected for a number of weeks. Because NoV cannot 
be cultured in vitro (2), it has remained impossible to assess whether the viruses shed 
by such patients are still infectious. The finding that noroviruses evolved within 
chronic patients suggested that detailed molecular virological data in combination 
with epidemiological data could be used to track possible routes of NoV transmission 
within the hospital (9, 10).      
 
Epidemiological records for all NoV positive patients diagnosed between 2005 and 
2007 were retrieved from the Erasmus Medical Center (EMC) data bank, including 
admission dates, sampling dates and departments. Fecal samples associated with these 
cases had been stored at -80C. Patient samples were sequenced as previously 
described (9). Briefly, the P2 domain of the ORF2 with a length of approximately 700 
nucleotides was sequenced in both directions using the ABI Prism BigDye Terminator 
version 3.0 ready reaction cycle sequencing kit. Strain sequences from patients with 
chronic NoV had been described previously (5). Norovirus positive patients 
hospitalized in the same period (defined as six months before to six months after the 
first sampling of all chronic shedders) were selected, and their stool samples were 
used for analyses. Only strains that were unique and showing clustering with the 
chronic patients were included. This selection was made to represent background 
diversity of norovirus strains circulating within the hospital. The strain sequences 
circulating in the community were represented by strains diagnosed at day 0 after 
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admission. To identify patients who may have been nosocomially infected by chronic 
shedders (5), strain sequences were obtained from patients that were routinely 
hospitalized with various disorders excluding NoV as a cause. The obtained 
sequences were identified on bases of 100 % identity to sequences previously 
obtained from chronic shedders over a minimum fragment length of 600 nucleotides. 
The sequences were subsequently analyzed using TREECON For Windows (8) with 
the neighbor joining method (single rooted) followed by bootstrapping. (Fig. 1) 
During the study period, we found three molecular clusters containing sequences of 
patients who had been recognized as chronic shedders patients and other hospitalized 
patients; two clusters consisted of genotype GII.4-2006a and one of GII.3 strains (Fig. 
1, Table 1). Chronic patient 6 (numbering corresponding with reference (5)) was 
admitted to the hospital multiple times, while chronic patients 4 and 8 stayed in the 
hospital, mainly in the same location during their norovirus infections. They were 
sampled and tested for NoV repeatedly during their admissions or visits, and 
sequences identical to theirs were detected among other admitted patients. Based on 
molecular information combined with demographic data the most probable direction 
of transmission was assumed to be from the chronic patients to other hospitalized 
patients. The transmissions between chronic patients 4 and 6, and the other patients in 
the two GII.4 clusters occurred shortly after the chronic patients were first diagnosed 
(sequence tree not shown). In the GII.3 cluster, transmission was detected both shortly 
after initial diagnosis of the chronic patient (involving at least five other patients), and 
also after a longer interval (involving one patient; NT23) (Fig. 1). The patients who 
were infected during the first week of this hospital outbreak, all shared identical 
sequences in the genomic region analyzed. The sequence of the NoV strain detected 
from the second sample drawn on day 17 in chronic patient 8 showed one nucleotide 
difference compared to the strain detected on day 0, and was identical to that of 
patient NT23, whose onset of disease occurred 20 days after the onset of disease of 
chronic patient 8. This strongly indicates that this patient, a 6-month-old ex-premature 
child with symptomatic nosocomial infection, was infected by chronic patient 8, at 
least 17 days after the first time norovirus was detected in patient 8 (day 0). The NT 
patients were hospitalized concurrently with patient 8 except for NT 19, 20, 22; they 
were admitted three to six days before chronic patient 8, followed by NT 23 who had 
been admitted almost two months earlier than chronic patient 8 as indicated by the 
blue bars in figure 1.  Two other clusters that included chronic shedders remained  
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unresolved with respect to the direction of transmission, because all cases were 
diagnosed within a few days. However, patient 4 already had chronic diarrhea prior to 
hospitalization, which was resistant to treatment and coincided with chronic shedding 
of NoV. Therefore, it is plausible that this is a second example of transmission from a 
chronic shedder. Evidence was most convincing for patient number 8, for whom the 
second sample (taken at day 17) showed a unique mutation that was identified in 
another patient hospitalized in the same ward. As this sequence was unique in the 
entire dataset, a link with the chronic shedder is highly likely. However, sources of 
NoV in the hospital may vary from patients to staff, contaminated environments and 
food items and despite extensive outbreak investigations, the exact modes of 
transmission often remain unclear. This study, however, shows that chronically 
infected patients may contribute to the spread of NoV in hospitals. To our knowledge 
this is the first study that provides evidence for this hypothesis and  points at an 
important aspect of infection control: contrary to earlier beliefs, patients who had 
NoV illness may shed the viruses for weeks, and recent data suggest that chronic 
shedding is relatively common in persons with impaired immune functions who 
contract the illness. Given the high incidence of NoV infections and the increasing 
size of the population that is immunocompromised, this problem is likely to increase 
in the years to come (4). Therefore, as part of infection control policy in the hospital, 
the possible contribution of such patients to nosocomial spread should be considered. 
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Summary 
Norovirus has become an important agent of gastroenteritis worldwide, including the 
Netherlands, causing large and small outbreaks in various health care settings and age 
groups. The high numbers of reported outbreaks in the Netherlands, with a substantial 
public health impact, have raised questions about control of norovirus outbreaks in 
high-risk settings. Previous studies have enhanced the understanding of the clinical 
impact and the epidemiology of the virus, but the knowledge of transmission remains 
limited [1, 2]. 
The focus of this PhD project was to enhance insights into the understanding of the 
introduction and the spread of the virus during outbreaks, using a range of methods 
for molecular typing and epidemiological studies, to improve the evidence basis for 
targeted prevention strategies. 
Norovirus outbreaks are difficult to control and will remain a challenge to public 
health in the years to come, particularly in nursing homes and similar healthcare 
settings. However, implementation of appropriate infection control measures is 
critical to controlling an ongoing norovirus outbreak. Stringent infection control 
practices are necessary for closed facilities including healthcare settings where the 
close proximity of residents may facilitate rapid spread of Noroviruses. 
Unfortunately, our understanding of this important area is significantly deficient and 
requires further study. Methods that allow identification of transmission links, both at 
the level of outbreaks and at the level of individual cases may greatly enhance our 
understanding of the ecology of these viral pathogens. 
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The impact of norovirus transmission in nursing homes and tertiary care hospital 
environments 
 
Norovirus transmission has been reported in many community care-based settings, 
and possible modes of transmission and sources of introduction of these viruses have 
been studied [3].  Since norovirus is highly contagious, infected symptomatic 
individuals within health care settings can easily transmit the virus among both 
patients and staff through infectious excreta, via person to person contact and 
contaminated surfaces [4]. 
Previous studies in residential settings revealed a high incidence of non-suspected 
viral gastroenteritis, where norovirus was found in 86 % of the studied outbreaks [5]. 
Another study performed in the Netherlands  showed that about 70 % of all the 
outbreaks caused by norovirus occurred in nursing homes and homes for the elderly 
and  predominantly consisted of person to person transmission [6]. 
 
Our findings confirm that nosocomial norovirus outbreaks are common, usually 
requiring closure of the affected department. Among the prospectively monitored 
outbreaks in this study, nursing homes were in majority and were greater in size 
compared with the hospital outbreaks (sukhrie et al, unpublished).  
Further to our understanding, once the virus is introduced in these settings with high 
contact rates, it can easily start an outbreak and subsequently cause serious disruption 
of the working routine. Patients with norovirus infections require additional care and 
they may infect health care workers who deal with these infectious patients on a daily 
basis. In addition, the workload for the health care workers increases further due to 
sick leave of colleagues. Recent studies have suggested that exposure of immuno-
compromised patients and elderly residents to norovirus could result in fatal infections 
[7, 8]. 
 
Another important consequence is closure of the affected department; temporary stop 
of admissions, and implementation of control measures, causing substantial financial 
losses during norovirus outbreaks. These findings implicate that advanced protocols 
and control measures are needed to eliminate transmission in an early stage of 
circulation of the pathogen. As recently demonstrated, application of control measures 
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in the earliest stage during an outbreak can help to prevent secondary infections and 
control of the outbreak [9] 
Currently there are many guidelines and outbreak management protocols in use at 
health care institutions worldwide aiming to prevent and control norovirus outbreaks 
in high risk settings [10]. These protocols focus on hygiene interventions: adequate 
hand hygiene for suspected norovirus cases and any contacts, including staff; isolation 
gowns and gloves for contact with incontinent persons during outbreaks, and at every 
moment there is risk of contamination with infected vomitus or feces. Furthermore, 
quarantine measures may be taken:  such as use of private rooms or cohorting to 
segregate suspected norovirus cases, and finally, disinfection measures such as regular 
cleaning of contaminated surfaces. Despite knowledge of these guidelines, norovirus 
outbreaks seem to be increasing worldwide, suggesting that current application of 
these control measures is insufficient in reducing norovirus transmission [11]. As the 
focus of intervention measures is on limiting transmission during outbreaks, there is 
limited understanding of how the virus is introduced into healthcare settings. It is 
likely that the high incidence of infection, including many asymptomatic infections, 
causes the virus to be easily introduced into nursing homes and tertiary care hospitals, 
due to the continuous exchange and admissions of patients and visitors. Once the 
virus has been introduced, mitigating or preventing transmission is difficult and 
usually too late: even the best hand washing procedures and eradication protocols may 
fail to curb an outbreak. On the other hand, hygiene interventions remain important in 
limiting the spread of the virus and thus the impact of an outbreak [10]. 
 
 
Routine surveillance and tackling introductions and (nosocomial) transmissions of 
noroviruses 
Outbreaks of norovirus often remain undiscovered and the source of the virus usually 
remains unknown. By the time norovirus infection is diagnosed, transmission is 
already ongoing and several subjects may have contracted the virus. Currently, 
emphasis is on enforcing increased hygiene during norovirus outbreaks, but sources of 
introduction, nosocomial infection and transmission are rarely studied or described. 
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Our studies indicate that introduction of the virus is a key element of transmission 
which should be included into measures for reducing virus spread (sukhrie et al, 
unpublished) [4, 12]. 
Our observations also indicate that norovirus screening and detection in healthcare 
settings is suboptimal, which may lead to increased diagnostic- and treatment costs, as 
well as complications in frail patients with immuno-suppression. In one of our studies 
we demonstrated that systematic screening of patients whose fecal samples were 
submitted to the laboratory (instead of testing at clinician request only), almost 
doubled the number of infections detected [13]. In characterization of another 
prospective outbreak we found that enhanced sampling yielded a 232 % increase in 
cases, including asymptomatic patients, symptomatic and asymptomatic health care 
workers [14]. These findings clearly indicate that norovirus infections are frequently 
missed. 
Using a database of retrospective outbreak data in a tertiary care hospital documenting 
nosocomial spread of the virus, it was shown that five of the 14 clusters involved at 
least one outpatient, thus indicating that targeting these outpatients may improve the 
infection control measures and perhaps limit introduction and (nosocomial) norovirus 
transmission [3]. 
Therefore, demographics, behaviors and additional contextual data of infected 
subjects in outbreaks should be reviewed to study their roles in the transmission 
network. However, collection of such data proved challenging, particularly for HCW, 
since very little information is available. Lack of knowledge about the source of the 
virus in many of the studied outbreaks is of concern, since we can only speculate 
about the effectiveness of measures aimed at preventing virus introduction. 
Norovirus sources are difficult to characterize and it often remains unclear where the 
outbreak strain originated. Since noroviruses are widely circulating in the community, 
this is always a likely reservoir. For instance, as we have seen during our studies, 
strains from patients exclusively visiting the emergency unit were sometimes identical 
to strains that later caused an outbreak in the same hospital, based on comparison of 
P2 domains (600 bp) [3]. This study demonstrates that sporadic strains from the 
community can become epidemic and cause outbreaks. Therefore, such introductions 
of sporadic strains into a nursing home or hospital should be investigated in more 
detail. The means of introduction is also a factor of concern, with emphasis on 
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purpose of contact such as occasional visitors, or healthcare workers with daily access 
to the hospital or nursing home. In one of our recent studies we demonstrated that 
norovirus might be introduced by both HCWs and patients (Sukhrie et al, 
unpublished). Based on their self-reported data we could conclude that they might 
have contracted the virus outside the institution, e.g. sick family members. Our studies 
also show, however, that in many instances, the source of (introduction) of the virus 
cannot be unambiguously identified.  
Once introduced, noroviruses spreads particularly well in healthcare settings, leading 
to nosocomial infections. A special impact is on immunocompromised patients that 
may not be able to clear norovirus and shed norovirus for a prolonged period of time, 
as we have seen in one of our studies. These shedders may constitute an important 
role within the health care setting and may act as reservoir for norovirus [15]. 
Therefore, contact with these chronic shedders requires special attention. 
Transmission of noroviruses from an ongoing outbreak may also occur where for 
instance health care workers working on an outbreak unit may concurrently service a 
non-outbreak unit. Recently a study demonstrated that health care workers employed 
at different facilities introduced the virus into at least three of their other working 
locations [16]. Thus, HCW are likely to play an important role in transmission 
because of their mobility, their contacts with patients or residents and various 
extramural environments. For this reason, we surmise that HCW may be important as 
a link between cases even though we have documented that their probability of 
transmission is smaller than that of patients or residents. Within the contact network, 
their higher connectedness, compared to patients or residents, may be important for 
carrying an outbreak across environment boundaries. Both health care workers and 
patients can act as key transmitters and cause secondary cases. Superspreaders, who 
cause more secondary cases than most others as recognized from our possible 
transmission trees, also deserve special attention, because knowledge of any factors 
that render an infectious subject a superspreader, may help in targeting more effective 
intervention procedures. 
Routine testing of norovirus, particularly subjects with symptoms may help to obtain 
insights into the introduction of the virus either by symptomatic or asymptomatic 
cases even though within outbreaks, asymptomatic cases seemed not as effective in 
transmitting the virus as symptomatic cases [14]. Additional information about the 
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mechanisms involved in transmission may be obtained by assessing questionnaires 
collected during an outbreak, which may provide self-reported case histories, 
systematically assessing possible sources (other patients, personnel, visitors, 
environment, food etc.) and transmission routes. 
 
We have shown that the combination of transmission analysis and contextual data 
obtained from questionnaires revealed important clues to identify index cases in the 
studied outbreaks. In view of the crucial role of infected health care workers we 
noticed that the sick leave for this category can range from 48 hours up to 6 days. It is 
important to note that virus shedding may last up to 60 days or more, while symptoms 
last a week or less. However, based on studies reported in this thesis, transmission 
from an asymptomatic health care worker is not likely. Therefore, HCW  returning to 
work as soon as their symptoms have disappeared, should not cause additional cases, 
as long as they comply with hygiene protocols [4]. On the other hand, symptomatic 
patients have the largest contribution to virus transmission during nosocomial 
outbreaks. Since all the prospectively monitored outbreaks occurred during the winter 
season, screening of patients at admission particularly during the winter combined 
with rapid strain typing, and (anonymized) linking of illness reports from healthcare 
workers to those in patients may contribute to earlier detection of clusters. Thus, 
strategies can be designed to decrease the impact of specific introductions, and to 
develop evidence-based recommendations for the prevention and control of norovirus 
outbreaks in hospitals and nursing homes. 
 
 
Rapid testing and combination with Real Time PCR 
Due to the rapid transmission of noroviruses, rapid control measures are needed for 
infected patients and health care workers to break the chain of transmission. 
Therefore, quick diagnosis of noroviruses is crucial, requiring highly sensitive, and in 
particular, rapid testing.  If testing takes too long and if noroviruses are missed during 
testing, unidentified infectious subjects might be able to rapidly transmit the virus 
resulting in a growing outbreak. 
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Sensitive testing currently implies real time PCR (RT-PCR), which requires highly 
trained personnel, and is difficult to implement in nursing homes and homes for the 
elderly. Such “gold standard” assays are expensive and often slow. Efforts are 
underway to decrease the time to diagnosis with RT-PCR, but currently the procedure 
for norovirus still takes too long, particularly when tests cannot be done onsite. We 
have seen in outbreaks that nursing homes do not have a point-of-care test: and in 
most of the cases samples are sent for testing to external laboratories, resulting in a 
delay of  approximately one week before the results are reported (Sukhrie et al, 
unpublished). 
Therefore, effective and rapid testing is instrumental in initiating control measures as 
early as possible. A bedside test or a point of care test is appropriate in settings with 
less comprehensive laboratory facilities, but highly trained personnel. Such tests are 
less sensitive than RT-PCR, which may cause false negatives based on rapid testing. 
However, different evaluation studies have shown that these methods are more 
successful in detecting the GII variants, rather than the GI strains [17-19]. Since the 
GII viruses cause the majority of the outbreaks in these settings, balancing the slower 
but sensitive and specific RT-PCR test with the rapid but less sensitive and specific 
bed side test could be a viable solution to diagnose norovirus more rapidly.   
A competing challenge is the amount of testing during norovirus outbreaks, and 
testing for routine screening. Since numbers of norovirus cases are increasing, a less 
labour intensive and rapid test is useful. A recently developed BLEIA (bioluminescent 
enzyme immunoassay) test, which is operated by an automated device and does not 
involve complicated procedures, can be used at hospitals and clinical laboratories to 
rapidly test large numbers of samples. [20]. 
 
Besides detection of the virus, typing should also be part of routine outbreak 
investigations, to help identify clusters. Recently it was demonstrated that applying 
sequence typing during an outbreak within a short period of time revealed four 
different strains, indicating multiple introductions and limited nosocomial 
transmission [21]. Such findings can be very helpful for decision makers and health 
professionals to guide control measures. For instance, when there is no nosocomial 
transmission but only multiple introductions, closing the facility is not necessary. 
During follow-up specific measures could be implemented to characterize these 
introductions. For reliable strain differentiation, P2 domain sequence typing is 
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required, to avoid misclassification of strains of the same genotype, particularly to 
recognize pseudo outbreaks during outbreak surveillance and multiple introductions at 
the same time of the same strain [12]. 
 
 
 
Molecular characterization and accumulation of mutations of the Norovirus genome 
in the context of tracking transmission 
 
Molecular characterization for norovirus is widely used for diagnostics. As described 
earlier, mapping of clusters and identification of nosocomial transmission are usually 
based on epidemiological data, like concurrent location and timing [3, 12]. However, 
we have shown that using only time and location, and norovirus diagnosis, 
misclassification of outbreaks and cluster mapping can occur [12]. 
To unambiguously characterize transmission during outbreaks, a combination of 
detailed molecular and epidemiological data is required [3]. We have demonstrated 
that understanding of these combined observations (Molecular and Epidemiological 
data) provides a scientific basis for transmission tracking and consequent control 
measures [3, 12, 14, 15]. Molecular linking of cases, and outbreaks, may be used as a 
tool to unravel the ecology of pathogens, but understanding the rate of genetic change 
is essential to design evidence-based sequence typing for use in epidemiological 
studies. Noroviruses have an RNA genome in which mutations accumulate at a high 
rate [22]. Since a person infected with a single infectious particle may shed many 
millions of progeny viruses, the majority of these are likely to have one or more 
mutations compared to the parent virus. Some of these altered sequences may be 
successfully transmitted. Studies have reported the rapid change in the P2 domain 
expressing the outermost capsid protein, which can interact with both carbohydrates 
(CHOs) and antibodies [23, 24]. Recurrent emergence of new epidemic norovirus 
strains can be expected with norovirus antigenic drift, which allows for noroviruses to 
evade the human herd immunity [25].  
Molecular analysis suggests that norovirus evolution is driven by immune selection 
but infections in healthy individuals result only in limited and short term immunity 
[26]. Therefore, these evolutionary changes seem likely to occur in people with 
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compromised health (immunocompromised, elderly), where long term shedding and 
substantial changes in viral genomes have been described [27, 28].  
Understanding the rate of change is essential to design evidence-based sequence 
typing for use in epidemiological studies, [3, 12, 29]. We found  that P2 domain 
sequence changes do occur during outbreaks but found a maximum of two nucleotide 
changes within a limited time frame of the studied outbreaks [12] Some of these 
contained mutations leading to amino acid changes possibly involved in the receptor 
binding patterns of the virus [12, 30]. 
As previously suggested, recombination may an important mechanism for the 
emergence of new strains including interchange of genomic regions (P1 and P2 
domain) and exchange of antigenic elements [31, 32]. During our transmission 
studies, no mechanisms of recombination and exceptional interchanges of the gene 
encoding the partial capsid protein were observed. The circulation of Norovirus in the 
general population and their sustained circulation in selected risk groups may 
contribute to a reservoir generating for new variants, which in turn could cause new 
outbreaks. If that is the case, interventions in these risk groups could potentially 
influence the (global) epidemiology of Norovirus. Possibly, further classification of 
strains using deep sequencing during outbreaks and regular screening from the general 
population could help to identify minor and major variants, as well as epidemic 
variants and the possible direction of transmission [33, 34] . 
Our understanding of the evolutionary mechanisms is still developing: predominant 
use of the P2 domain as a marker in tracking transmissions will likely result in the 
discovery of noteworthy mutations within this domain. The focus of sequencing 
should be extended by focusing advanced methods providing higher resolution P2 
domain sequence data. For instance distinguishing minor strains from the major 
strains during outbreaks per sampled individual or sequencing larger parts of the 
genome (or the whole genome) may help in identifying specific routes of person-to-
person transmission. 
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Concluding remarks and future perspectives 
 
To understand transmission pathways of norovirus between the general population 
and health care setting, and within health care settings, a standardized approach to 
outbreak investigations, using validated methods is needed. Importantly, collecting 
data on the extent of transmission of norovirus during outbreaks, factors contributing 
to their introduction and spread, and data on diversity of the genomes of viruses shed 
by people over subsequent chains of transmission can be used to identify transmission 
networks and possibly lead the way to control measures as discussed previously. 
However, collection of such data is quite challenging in nursing homes and elderly 
homes with limited resources and personnel. At the start of the study, the research 
nurse gave presentations and distributed flyers explaining the study to health care 
workers in each of the involved institutions. The studies had been endorsed by the 
management, and a member of our team supported HCW in administration of 
questionnaires and sampling logistics.  Despite this, we have seen that even 
performing prospective controlled outbreak studies was challenging in these settings, 
resulting in many non-responders and generally limited interest for such research. In 
part this can be explained by the workload:  as during outbreaks, the health care 
workers and patients are under strain from worsening conditions and challenges 
imposed by outbreak protocols, such as intensified hygienic measures. We have also 
experienced that the transition from a normal routine to an outbreak routine can be 
quite labor intensive due to sick leave of colleagues and application of control 
measures. This may also have motivated the decisions of patients and health care 
workers to withdraw from the study. 
Creating awareness is an essential start, perhaps launching effective campaigns about 
the consequences of norovirus outbreaks in the home environment, rather than 
focusing on particular settings. This should convince institutions and health care 
workers of the importance of norovirus transmission research in this field. 
A relatively straightforward routine practice could be screening of health care workers 
and patients sharing wards with norovirus cases as part of the outbreak investigations, 
with storing of  samples for analysis if needed, for instance if an outbreak persists. 
This should be accompanied by a standardized and short questionnaire to obtain 
demographics and behavioral notes of patients diagnosed with norovirus symptoms on 
routine basis. These demographics should at least include the food consumed and 
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where that person might have contracted the virus (household members, friends, and 
contacts). Our work shows that particular emphasis is needed to gain insights on the 
origin of the outbreaks, in particular where there is additional knowledge from the 
self-reported questionnaires focusing on context e.g. personal hygiene and physical 
contact with other occupants. Similar systematic or behavioral studies should be made 
of the contact behaviors of health care workers and their roles in the transmission 
chain of noroviruses. Such information can provide critical support for decision 
making for infection control staff, municipal health services and food safety 
inspectorates. We have seen that the majority of the outbreaks in this study(5 out of 7) 
were caused by the GII.4 strain, as this is the most common circulating strain 
attributed to major outbreaks, particularly in health care settings. Work done in a 
European research network coordinated by National Institute for Public Health and 
the environment in the Netherlands has also shown that in the past 12 years four 
successive GII4 variants emerged and caused worldwide epidemics [35, 36]. 
Therefore, particular focus on this genotype variant is highly required in these 
settings. It is also important to focus on the understanding of the rate of genetic 
changes, which is essential to design evidence-based sequence typing for use in 
epidemiological studies. In addition to collecting data on onset of symptoms and 
locations of cases, fecal samples should be collected whenever possible. P2 domain 
linking should be a routine in outbreak characterization combined with collecting self-
reported contextual data of suspected individuals (health care workers and patients). 
However, further additional analysis of this domain is needed with regard to sequence 
changes in a given outbreak among strains of the same origin and within any affected 
individual in a subsequent time frame. We have shown that within outbreaks, minor 
variation in the P2 domain may be found, and that the probability of finding sequence 
changes increases with time.  To better characterize P2 domain variation within 
outbreaks prospective follow-up studies on infected individuals (health care workers 
and patients) are required, to ultimately validate the cut-off we have suggested for 
current analysis and strain segregation. During our study we could not reach the 
targeted numbers of outbreaks due to limited occurrence of outbreaks within the study 
period. There were lots of cases during the outbreaks that tested negative although 
they were screened within the outbreak criteria and displayed norovirus symptoms 
resulting in limited numbers of  samples[14]. As previously mentioned, more samples 
and advanced sequencing (next generation sequencing) could be very useful to 
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systematically validate the P2 domain and perhaps other regions of the norovirus 
genome for transmission analysis [33, 34]. In conclusion, this study showed that 
current techniques for preventing the spread of norovirus in health care settings are 
inadequate due to the rapid nature of virus transmission. We recommend both further 
molecular analysis to identify sources of infection to be made routine, as well as 
development of rapid diagnostic tools to reduce the incidence and spread of infection 
in these vulnerable groups of people. 
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Samenvatting 
 
Norovirus (NoV)-infecties zijn de meest voorkomende oorzaak van buikgriep bij 
personen van alle leeftijden. Daarnaast zijn NoV’s berucht als veroorzaker van 
uitbraken in zorginstellingen, op cruiseschepen en in restaurants. Dit proefschrift 
beschrijft onderzoek gedaan van 2008 tot en met 2012 in zorginstellingen in de regio 
Rotterdam, met als doel beter inzicht te krijgen in de introductie en verspreiding van 
NoV als basis voor het ontwikkelen van evidence-based richtlijnen voor bestrijding. 
Het doel van deze studie was om systematisch onderzoek te doen naar bronnen van 
infecties en contacten tussen geïnfecteerde patiënten teneinde inzicht te krijgen in de 
herkomst van de virussen en de wijze waarop NoV zich verspreidt binnen besmette 
afdelingen. Beter begrip van de transmissie is cruciaal om beleidsmakers te 
informeren over optimale preventie- en interventiestrategieën, met name in 
instellingen met een hoog risico. Binnen deze kaders, was het een specifiek doel om 
criteria te ontwikkelen voor het gebruik van moleculaire diagnostiek en typering bij 
bronopsporing. Hiervoor is bij een aantal uitbraken gedetailleerd onderzoek gedaan 
naar de verspreiding van de infectie, de bijdrage aan de verspreiding van personen 
zonder ziekteklachten, en factoren die zouden kunnen bijdragen aan vroegtijdige 
signalering.  
Omdat infecties met NoV heel vaak gemist worden, is in eerste instantie de 
onderdiagnose van NoV in een groot academisch ziekenhuis geëvalueerd, zoals 
beschreven in hoofdstuk 2. Door systematische screening van fecesmonsters van alle 
personen waarvoor fecesonderzoek werd aangevraagd (in plaats van alleen de 
aangevraagde test) gedurende een periode van 6 maanden, werd het aantal NoV-
diagnoses verdubbeld. Cases die gemist waren in de routinediagnostiek bleken hun 
oorsprong te hebben in 5 van de 6 NoV-uitbraken die in deze periode plaatsvonden 
binnen de onderzochte instelling. Niet onderkende NoV-infecties verschilden klinisch 
niet van NoV-infecties waarbij de diagnose wel gesteld was, en waren 
kostenverhogend door duurdere diagnostiek en verdergaande transmissie tijdens 
uitbraken.  
Om de verspreiding van het virus binnen deze instellingen (nosocomiale transmissie) 
verder te onderzoeken, is in hoofdstuk 3 een (andere) retrospectieve studie opgezet 
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waarbij nosocomiale transmissie werd geëvalueerd bij patiënten met de diagnose 
NoV, die waren opgenomen in het ziekenhuis tussen 2002-2007. Bij ca. 60% van de 
opgenomen patiënten werd de diagnose NoV 5 dagen na opname gesteld, wat 
suggereert dat de bron van de infectie waarschijnlijk in het ziekenhuis lag. 
Bestudering van de verzamelde moleculaire virusdata leidde tot nieuwe inzichten, 
zoals waargenomen in 5 ziekenhuisclusters (uitbraken), waarbij sommige patiënten 
alleen de polikliniek hadden bezocht, waar ook het virusmonster werd afgenomen. 
Deze cases waren dus niet opgenomen in het ziekenhuis, wat erop wijst dat deze 
patiënten bronnen van introductie van het virus kunnen zijn.  
De vergaarde inzichten zijn gebruikt in hoofdstuk 4 om de mate van verspreiding in 
het ziekenhuis en de bijdrage van verschillende genotypen van NoV in beeld te 
brengen. Uit zorgvuldig prospectief onderzoek bleek dat NoV-infectie bijna tweemaal 
zo veel voorkwam dan routinematig herkend, met name onder personeelsleden (met 
en zonder klachten), en onder patiënten zonder ziekteklachten (buikgriep: braken, 
diarree), hoewel de uitbraken in het algemeen snel onder controle waren. Uit analyse 
van moleculaire typeringen, in combinatie met epidemiologische gegevens, bleek dat 
personeelsleden en patiënten met ziekteklachten het meeste bijdragen aan 
verspreiding, terwijl NoV-positieve personeelsleden zonder ziekteklachten nauwelijks 
bijdragen aan virusverspreiding. Dit is opmerkelijk, aangezien bij klachtenvrije 
infecties grote aantallen virussen kunnen worden uitgescheiden, gedurende enkele 
maanden na infectie. Afwezigheid van verspreiding door klachtenvrije 
personeelsleden is belangrijk, vooral in verband met maatregelen om de verspreiding 
van het virus tegen te gaan. Na verdwijnen van de symptomen van acute ziekte kan 
zorgpersoneel veilig weer aan het werk, mits men de regels voor hygiëne (handen 
wassen) zorgvuldig in acht neemt.  
Geïnfecteerden besmetten anderen doordat ze het virus uitscheiden. Over NoV-
uitscheiding in relatie tot transmissie is weinig bekend, vooral als het gaat om 
verspreiding tussen de verschillende soorten patiënten en personeelsleden in een 
gezondheidsinstelling. In hoofdstuk 5 is de uitscheiding van NoV bij patiënten en 
medewerkers bestudeerd, door middel van een kwantitatieve PCR-methode. Door 
middel van een wiskundig model is bepaald hoe de uitscheiding van NoV verloopt: na 
infectie een snelle stijging, het bereiken van een maximum, gevolgd door een 
langzame afname. Symptomatisch en asymptomatisch geïnfecteerden bleken 
eenzelfde uitscheidingspatroon te vertonen. Bovendien werd waargenomen dat zowel 
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symptomatisch als asymptomatisch geïnfecteerden soms maandenlang NoV kunnen 
uitscheiden. Ondanks deze langdurige uitscheiding zijn er overigens geen 
vervolguitbraken gezien die door eenzelfde virusstam werden veroorzaakt. 
In alle geobserveerde uitbraken zijn sequenties van het P2-domein als moleculaire 
marker gebruikt om clusters te classificeren; infecties binnen eenzelfde cluster hebben 
identieke P2-sequenties. Een validatie van deze methode is nog niet eerder 
gerapporteerd. Daarom zijn in hoofdstuk 6 alle vergaarde P2-domeinen van alle 
uitbraken in detail geanalyseerd. Hierbij werd een pseudo-uitbraak ontmaskerd: een 
cluster dat geclassificeerd was als 1 uitbraak op basis van epidemiologische gegevens 
bleek uiteen te vallen in twee onafhankelijke delen. Binnen de onderzochte uitbraken 
is gebleken dat de P2-marker genoeg resolutie biedt om uitbraken en virusstammen 
van elkaar te scheiden, en zodoende transmissieketens en bronnen op te sporen. 
Sequentieveranderingen binnen het P2-domein worden wel gezien, zelfs binnen een 
enkele uitbraak veroorzaakt door dezelfde stam. Bij een gedetailleerde analyse bleek 
dat kleine veranderingen (enkele baseparen) voorkomen over het gehele P2-domein 
en dat zij soms tot aminozuurveranderingen hebben geleid. Toenemende kans op 
verandering werd gezien vanaf dag 5 na infectie, waarbij na drie weken gemiddeld 
10% kans bestaat voor nucleotideverandering; de kans op verandering neemt toe met 
het verloop van tijd. Hieruit blijkt dat het P2-domein een nuttige marker is om te 
gebruiken tijdens uitbraken. 
Om het begin van uitbraken (introductie van het virus) in kaart te brengen, hebben we 
uitbraken gevolgd van 2009 tot 2011, waarbij aanvullende gegevens werden 
verzameld door middel van vragenlijsten, zoals beschreven in hoofdstuk 7. Het bleek 
lastig om zulke gegevens te verzamelen bij patiënten en medewerkers tijdens een 
uitbraak. Dit onderzoek toont aan dat de uitbraken sterk verschilden in grootte en 
duur, terwijl zowel patiënten en medewerkers als mogelijke indexcases (eerste 
infectieuze persoon) konden worden geclassificeerd. Incidenteel bleek het wel 
mogelijk om een waarschijnlijke introductiegebeurtenis te achterhalen, maar meestal 
was eenduidige identificatie niet mogelijk. Om virusintroductie beter te kunnen 
beschrijven zijn meer gegevens en vooral snellere monstername nodig.  
In hoofdstuk 8 is uitscheiding van NoV beschreven voor drie chronische 
uitscheiders, tijdens ziekenhuisuitbraken. Door de moleculaire marker (P2-domein) te 
gebruiken in combinatie met patiëntgegevens kon worden aangetoond dat transmissie 
was opgetreden vanuit deze chronische uitscheiders naar andere opgenomen patiënten 
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binnen het ziekenhuis. Hieruit blijkt dat deze patiënten potentiële bronnen zijn voor 
NoV-verspreiding binnen het ziekenhuis.  
Uiteindelijk zijn in hoofdstuk 9 alle verzamelde gegevens samengevat en 
bediscussieerd vanuit de vraag hoe NoV-uitbraken beter kunnen worden 
gekarakteriseerd, en vooral voorkomen.  
 
 
 
Conclusie en aanbeveling 
De opsporing van NoV-infecties in zorginstellingen is niet optimaal, wat kan leiden 
tot verhoogde diagnostiek- en behandelkosten, en complicaties bij kwetsbare 
patiënten met verstoorde immuniteit. Screening van patiënten bij opname 
(voornamelijk tijdens het winterseizoen), gebruik van snelle typering, en het 
(geanonimiseerd) koppelen van gegevens over ziekmeldingen bij personeelsleden en 
patiënten kunnen bijdragen aan vroegtijdige detectie van clusters.  
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